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ABSTRACT 
Computational protein design (CPD) is a burgeoning field that uses a physical-chemical or 
knowledge-based scoring function to create protein variants with new or improved properties. This 
exciting approach has recently been used to generate proteins with entirely new functions, ones that 
are not observed in naturally occurring proteins. For example, several enzymes were designed to 
catalyze reactions that are not in the repertoire of any known natural enzyme. In these designs, 
novel catalytic activity was built de novo (from scratch) into a previously inert protein scaffold. In 
addition to de novo enzyme design, the computational design of protein-protein interactions can 
also be used to create novel functionality, such as neutralization of influenza. Our goal here was to 
design a protein that can self-assemble with DNA into nanowires. We used computational tools to 
homodimerize a transcription factor that binds a specific sequence of double-stranded DNA. We 
arranged the protein-protein and protein-DNA binding sites so that the self-assembly could occur in 
a linear fashion to generate nanowires. Upon mixing our designed protein homodimer with the 
double-stranded DNA, the molecules immediately self-assembled into nanowires. This nanowire 
topology was confirmed using atomic force microscopy. Co-crystal structure showed that the 
nanowire is assembled via the desired interactions. To the best of our knowledge, this is the first 
example of a protein-DNA self-assembly that does not rely on covalent interactions. We anticipate 
that this new material will stimulate further interest in the development of advanced biomaterials. 
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Introduction 
Computational protein design (CPD) is an automated process that uses a physical-chemical or 
knowledge-based scoring function to predict amino acid sequences that will fold into a given 
three-dimensional structure. With current computational resources, over 10100 sequences can be 
virtually screened within a few CPU hours. The ability to efficiently search such enormous 
sequence space has allowed scientists to design novel proteins that could not be found with other 
protein engineering approaches (e.g., directed evolution). De novo protein design, i.e., designing 
proteins from scratch, is particularly challenging, and recently many investigators have focused 
their CPD efforts in this area. De novo computational design can be divided into two categories: 
full-sequence designs and functional designs. These are briefly reviewed below. 
Full-sequence designs 
Full-sequence design of a zinc finger domain 
The first full-sequence design was achieved in 1997 for a 28-amino acid ββα motif based on the 
backbone structure of a zinc finger domain (1). A combinatorial library of 1.9 × 1027 possible 
amino acid sequences was virtually screened and ranked using a physical chemical scoring 
function. The best (lowest energy) sequence, FSD-1, was chemically synthesized and its structure 
was confirmed by nuclear magnetic resonance spectroscopy. FSD-1 only shares 21.4% sequence 
identity to its design parent (Zif268), and a BLAST search showed that it has very low identity to 
any known protein sequence. This pioneering work demonstrated that the “inverse-folding” 
problem (finding amino acid sequences that can fold into a given backbone structure) could be 
solved with CPD, and the resulting sequence may be significantly different from nature’s solution.  
Full-sequence design of a novel globular fold 
The second breakthrough in full-sequence design was in 2003 with the creation of a novel 
globular protein fold called Top7 (2). Remarkably, this study did not use an existing protein fold 
for sequence design. Instead, the authors iterated between sequence space and structure space to 
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create a novel fold that did not exist in nature. Top7, a 93-residue α/β protein, was obtained via 
sequence optimization of a combinatorial library containing 10186 rotamers. Fifteen cycles of 
sequence design and backbone relaxation were used to obtain the final Top7 sequence. The Top7 
crystal structure is strikingly similar to the design model (backbone RMSD = 1.2 Å).  Moreover, 
its melting temperature (Tm) is above 99 °C, which reflects the accuracy of the force field and the 
modeling methodology.  This work showed that computational design can be used to create new 
protein folds, ones that have not yet been observed in nature. In addition, the study pointed out 
the importance of backbone relaxation during the sequence design process.  
Functional designs 
Enzyme design 
The success of full-sequence designs supported the validity of CPD’s structure-and energy-based 
approach for protein engineering. Thus, it seemed reasonable that if an energy-based score could 
be correlated with protein function, one should also be able to design a protein with desired 
functionality from scratch. The idea of designing a functional protein de novo was first realized in 
2001 with the design of a “protozyme,” a protein with p-nitrophenyl acetate hydrolysis activity 
(3). The design hypothesis was based on the transition state theory: a chemical reaction will be 
accelerated if the catalyst stabilizes the reaction transition state. In this study, the transition state 
molecule was modeled into the active site pocket of a catalytically inert protein scaffold. The 
catalytic residues, as well as the surrounding residues, were computationally designed so that the 
total energy of the system was minimized. The best design, PZD2, had a Km of ~170 µM, a kcat of 
~4.6 × 10−4 sec−1, and a kcat/kuncat of 180. This activity is comparable to that of early catalytic 
antibodies, but far below that of natural enzymes. 
 Two de novo enzyme designs with improved activities were reported in 2008. 
Rothlisberger et al. designed enzymes to catalyze the Kemp elimination reaction and obtained 
rate enhancements of up to 105 (4). Application of in vitro evolution to the original computational 
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designs led to even greater enhancements, resulting in  >200-fold increase in kcat/Km (2,600 
M−1s−1). Jiang et el. designed a retro-aldol enzyme that accelerated the reaction by 104 (5). These 
two landmark studies thus demonstrated the ability to create efficient biocatalysts for reactions 
that could not be catalyzed by naturally occurring enzymes. Recently, Privett et al. used CPD to 
design a Kemp eliminase (6); extensive directed evolution of this design was then performed (7), 
leading to an enzyme that accelerated the reaction 6 × 108-fold, approaching the efficiency of 
natural enzymes. This dramatic result illustrates that combining the two approaches, CPD and 
directed evolution, can be a powerful strategy for the generation of novel and highly sophisticated 
biocatalysts. 
Protein dimer design 
In addition to enzyme activity, another important property of proteins is their ability to associate 
and dissociate with other proteins. In 2011, Fleishman et al. designed a protein inhibitor that 
specifically binds the conserved stem region of influenza hemagglutinin (HA) (8). They 
computationally docked a library of protein scaffolds to a specified patch on HA, then designed 
the interface residues to favor these protein-protein interactions. Protein binders with Kds in the 
low µM range were created, and subsequent affinity maturation brought these values into the nM 
range. Crystallographic analysis confirmed that the bound structure closely resembled the 
computationally designed model. Because the conserved stem region of influenza HA was 
targeted, the designed proteins exhibited broad neutralizing activity against multiple influenza 
HA subtypes.  
 In addition to heterodimer designs, symmetric homodimer designs have also been 
attempted. In 2011, Stranges et al. exploited β-strand interactions to create a symmetric 
homodimer with a Kd in the low µM range (9). In 2012, Der et al. designed metal-protein 
interactions to mediate homodimer formation and obtained a molecule with a Kd in the low nM 
range (10). The Kd increased to the low µM range when the metal was absent. Importantly, in 
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both of these studies, X-ray crystallography confirmed that the homodimer structures were nearly 
identical to their design models. 
Protein-ligand design 
Another important function of protein is its ability to bind small molecules, such as secondary 
messengers. In 2013, Tinberg et al. used a computational approach to design ligand binding 
proteins (11). The proteins exhibited high affinity and selectivity for the steroid digoxigenin (Kds 
were in the µM and sub-nM range before and after affinity maturation, respectively). They 
determined the X-ray co-crystal structure of two of the designs and showed atomic-level 
agreement with the corresponding design models.  
Protein macrocrystal design 
In addition to the interactions between proteins that occur under physiological conditions, protein 
molecules also interact each other in the crystal form. In 2012, Lanci et al. designed the crystal 
contacts of a protein so that it would self-assemble in three dimensions to yield macroscopic 
crystals (12). The crystal structure of this design exhibited sub-Å agreement with the 
computational model. This work demonstrated that CPD can be used in a new way—to create 
macroscopic scale materials. 
Protein nanomaterial design 
In 2012, King et al. designed protein oligomers to form self-assembling nanomaterials (13). The 
self-assemblies are shaped like cages and mimic the symmetrical structures of viral capsids. 
Nevertheless, they have novel architectures with specified symmetries. X-ray crystallography of 
the cage structures revealed atomic-level agreement with the design models. The potential 
applications of nano-cages include biomedical applications such as drug delivery. This novel 
work suggests that the possible uses of CPD are just beginning to be explored, and that there are 
many ways in which it may contribute to materials science.  
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CPD: progress and possibilities for the future 
In the brief review given here, one can clearly see the progression of CPD: (1) full-sequence 
designs that serve as proof-of-principle studies; (2) functional designs that capture the properties 
of naturally occurring proteins, such as catalytic activity or protein/ligand binding, and apply 
them to new reactions or associations; and (3) functional designs that create large assemblies and 
novel functionalities for materials science applications, such as protein macrocrystals and 
nanomaterials.  This trend (Fig. 1-1) is very exciting because it appears that computational de 
novo design is becoming more versatile. In addition to creating novel proteins with desired 
biological functions (such as enzymes and binders), we can also endow proteins with new 
functions that naturally occurring proteins do not have (such as designed crystals and 
biomaterials). Despite the novelty of macrocrystal design and nano-cage design, these types of 
materials are not new—they either occur naturally or have been created in the laboratory. One is 
then compelled to ask, “Can we create a completely new type of material using CPD, and if so, 
what type of material will this be?” Both DNA alone and protein alone have been used to create 
self-assembling biomaterials, such as DNA origami (14) and protein fibrils (11). Materials that 
conjugate DNA and protein using chemical bonds have also been developed for interesting 
applications, such as immuno-PCR for sensitive antigen detection (15) and programmed 
positioning of multienzyme cascades (16). However, as far as we are aware, no one has created 
protein-DNA self-assemblies via purely non-covalent interactions. We therefore decided to see if 
CPD could be used to design a self-assembling protein-DNA nanomaterial.    
Designing a self-assembling protein-DNA nanomaterial 
To design a protein-DNA nanomaterial, one must incorporate the protein-DNA interaction plus at 
least one additional type of interaction (protein-protein or DNA-DNA) into the material. Our plan 
was to leverage the power of CPD and use protein-DNA and protein-protein interactions to 
assemble our protein-DNA nanomaterial. As the de novo design of protein-DNA interactions has 
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not yet been done, we decided to exploit the naturally occurring protein-DNA interaction 
described in this study. Engrailed homeodomain (ENH) is a monomeric protein that binds a 
specific sequence of double-stranded DNA in a 1:1 fashion (17). This protein has been 
extensively used for theoretical and computational studies, including many CPD studies. 
Importantly, it is a three-helix protein that primarily uses helix-3 for DNA binding. Helices 1 and 
2 are on the other side of the protein and do not contact the DNA; they form a flat surface that can 
potentially be designed as a homodimerization interface without disturbing the protein-DNA 
binding domain. It is therefore an ideal protein for designing a protein-DNA nanomaterial.  
Our plan was to homodimerize ENH using computational docking and CPD.  We 
reasoned that the ENH homodimer should be able to bring two fragments of target DNA into 
close proximity.  Furthermore, if we arranged two protein binding sites on opposite sides of a 
target DNA fragment, “linearization” of the DNA and the designed protein should spontaneously 
occur when the two components are mixed. We expected the self-assembly to form nanowires 
with a diameter equal to the length of the DNA fragment. The length of the nanowire would 
depend on the number of DNA fragments and proteins that associated with each other. The 
overall design scheme from wild-type ENH to the nanowire is illustrated in Fig. 1-2.  
 Although the most straightforward way of making this nanowire is to design ENH into a 
homodimer, the low stability of wild-type ENH (Tm = 49 ºC) makes this design extremely 
difficult. Attempts to computationally design an ENH homodimer resulted in aggregated proteins 
when expressed in Escherichia coli. We therefore employed an alternative strategy to overcome 
this problem. In a previous study, CPD was used to create a stabilized variant of ENH called 
NC3-NCap (Tm = 88 ºC) (18). Using NC3-NCap as the starting scaffold, we designed a variant 
that was characterized as homodimeric (ENH_DsD). However, X-ray crystallography 
unexpectedly revealed that the dimer was in fact domain-swapped. We therefore developed a 
molecular dynamics (MD) protocol to fix the domain-swapping problem. This is described in 
Chapter 2. We hypothesized that the hinge region involved in domain swapping would have 
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unusually high flexibility, and that this flexibility would be revealed in a short MD simulation. 
Our MD protocol predicted that a variant with a single proline mutation, E23P, could revert the 
domain-swapped ENH_DsD fold back to the wild-type ENH fold. We fused E23P with a yellow 
fluorescent protein (YFP), and determined its Kd value to be 10 nM using YFP fluorescence. The 
structure of E23P-YFP was experimentally confirmed by X-ray crystallography; it was 
homodimeric and retained the wild-type ENH fold. However, the homodimer was formed by the 
unexpected interaction between E23P and YFP.  
In Chapter 3, we describe our work characterizing the biophysical properties of E23P 
without YFP fused (renamed ENH-c2b). We found that this protein forms a homodimer with a Kd 
of ~130 nM. Nuclear magnetic resonance spectroscopy showed that its solution structure is 
similar to that of our design model. The success of the ENH-c2b homodimer design was achieved 
via a two-step approach in which wild-type ENH was first stabilized, and then this stable variant 
was dimerized using CPD. !
In Chapter 4, we describe how we designed a protein that can self-assemble with a 
particular DNA to form protein-DNA co-assembling nanowires. The resulting protein, dualENH, 
bound DNA specifically and still formed a homodimer. Upon mixing dualENH and DNA 
fragments that contained multiple protein binding sites, a DNA-protein self-assembly formed 
immediately, as shown by fluorescence microscopy. Atomic force microscopy revealed that the 
self-assembly formed nanowires if the DNA fragments were designed to have exactly two 
binding sites on opposite sides of the DNA helix. The width of the nanowire was ~15 nm, which 
is consistent with the length of the DNA fragment. The length of the nanowire was up to 300 nm. 
We solved the co-crystal structure of the nanowire. The crystal structure showed that the 
nanowire was formed via our designed interactions. 
 In summary, we used CPD to create a new material—self-assembling protein-DNA 
nanowires. The nanowire self-assembly relies on designing a protein with two functions: 
homodimerization and DNA binding. These two functions were implemented on two domains 
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that can work independently and cooperatively. Nature has often evolved multi-domain/function 
proteins to achieve complicated tasks (e.g., the DNA-binding and activation domains of 
transcription factors). Recent studies have demonstrated that CPD can be used for the de novo 
design of many individual functions. In this work, we showed that with judicious choices and use 
of computational design tools, two functions can be incorporated into a single protein such that 
novel functionality is created. In the future, we expect that CPD will be used in many new 
applications, perhaps by combining multiple functions in unique ways. The possibilities of de 
novo CPD are just beginning to be explored. 
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Fig. 1-1. Summary of de novo protein design history using CPD. 
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Fig. 1-2. Overall design scheme for a self-assembling protein-DNA nanowire. (A) The protein 
scaffold, engrailed homeodomain (ENH), is a monomeric protein with three helices. Helices 1 
and 2 (green) were chosen for homodimerization. Helix-3 (cyan) is the DNA-binding domain. (B) 
In silico docking was performed to generate a symmetric homodimer configuration using the 
structure in (A). (C) The interface of the docked homodimer from (B) was computationally 
designed to create protein-protein affinity. (D) Each component of the designed homodimer 
specifically binds a dsDNA fragment. The designed homodimer therefore can bring two dsDNA 
fragments into close proximity. (E) If each dsDNA fragment has exactly two protein binding sites 
located on opposite sides of the DNA helix, the designed homodimer (green and cyan) and the 
dsDNA fragment (red) will self-assemble into nanowires.  
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Chapter 2 
Using Molecular Dynamics to Predict Domain Swapping of 
Computationally Designed Protein Variants 
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Abstract 
In standard implementations of computational protein design (CPD), a positive-design approach is 
used to predict sequences that will stabilize a given backbone structure. Possible competing states 
are typically not considered, primarily because appropriate models for them are not available. One 
of the competing states, the domain-swapped dimer, is especially compelling, because it is often 
nearly identical to its monomeric counterpart, differing by just a few mutations in the hinge region. 
Molecular dynamics (MD) simulations provide a computational method to sample different 
conformational states of a structure. Here, we tested whether MD could be used as a post-design 
screening tool to identify domain-swapped dimers. We hypothesized that a successful 
computationally-designed sequence would have backbone dynamics similar to that of the input 
structure, and that in contrast, domain-swapped dimers would exhibit increased backbone flexibility 
in the hinge region to accommodate the huge conformational change required for domain swapping. 
While attempting to engineer a homodimer from the monomeric protein engrailed homeodomain 
(ENH), we discovered that we had instead generated a domain-swapped dimer (ENH_DsD). We 
ran MD on these proteins and, as expected, observed increased backbone flexibility in the hinge of 
the domain-swapped dimer. Two point mutants of ENH_DsD designed to recover the monomeric 
fold were then tested with our MD protocol. MD predicted that one of these mutants would adopt 
the monomeric structure, and this was confirmed by X-ray crystallography. Similarly, MD-
generated backbone dynamics was found to reflect the domain-swapping tendency of 
computationally designed variants of the IgG-binding domain of protein L.  
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Introduction 
Computational protein design (CPD) provides in silico tools that facilitate the identification of 
amino acid sequences with specific desired properties. Most CPD algorithms sample an enormous 
number of amino acid types and side-chain conformations to find the most energy-favored 
sequences in the context of a single, fixed, main-chain structure (1, 2). Leveraging the speed of 
modern computers, CPD can effectively reduce the vast sequence space to an affordable number of 
sequences for experimental examination. CPD is particularly useful when combined with medium 
to high-throughput experimental screening, and has led to successful designs for a variety of protein 
engineering problems (3-9). The utility of CPD, however, can be limited in applications where our 
understanding of the engineering problem is incomplete, or where an appropriate high-throughput 
experimental screening method does not exist. Another problem that can occur is that the designed 
sequence doesn’t fold into the desired structure, but instead takes on the conformation of a 
competing state, including unfolded or aggregated states. For example, Fleishman et al. (5) recently 
showed that only 2 of 88 CPD-designed variants from different protein scaffolds bound to the target 
molecule, influenza hemagglutinin. A community-wide assessment of this study suggested that 
many of the failed designs do not adopt the target fold (10). In addition, only half express solubly 
(11), probably due to poor stability. The ability to predict whether a designed protein sequence will 
be correctly folded and stable prior to evaluating it experimentally would be extremely beneficial, 
as it would filter out “poor sequences” so that time-consuming and expensive experimental 
validations need only be done on sequences that are more likely to have the desired properties. 
Although the conformational population of a protein depends on the relative energetic 
contributions of all possible states, most CPD methods evaluate designed sequences based on only 
one desired state. Consequently, even though the sequences obtained from these single-state designs 
may have good CPD scores, this does not ensure that the desired fold dominates the population, 
because other states may score better than the designed state. Unfortunately, modeling other 
possible states is not trivial because the conformations of these states are typically unknown.  
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The stability, specificity, and activity of a protein often depend not only on the protein’s 
structure, but also on its dynamic properties. Altering the dynamics may lead to undesired 
conformational pathways, such as amyloidogenesis (12). The goal of many protein engineering 
projects is therefore to maintain the basic structure and dynamics of the protein while improving a 
desired property (e.g., catalytic activity (13), thermostability (14), substrate specificity (15), ligand 
binding (16), and molecule transport (17)). However, protein dynamics is typically not modeled in 
CPD calculations. Fortunately, molecular dynamics (MD) simulations provide a powerful tool for 
exploring local ensembles of the native state and thus, when incorporated into CPD, allow protein 
dynamics to be included in the design process. Indeed, Allen et al. showed that MD ensembles 
could be successfully used for computational multi-state protein design (18).  
MD simulations can also serve as a complementary tool to evaluate the dynamic properties 
of CPD-generated proteins. Both Kiss et al. (19) and Privett et al. (20) used MD simulations as a 
post-CPD screening method in the de novo design of an enzyme to catalyze the Kemp elimination 
reaction. In these studies, the dynamics of the substrate in the designed active site was monitored 
using MD. The population of competing states (i.e., bound vs. not bound to substrate) was 
calculated in the MD trajectories of enzyme variants and used as a filter to identify those likely to 
exhibit Kemp elimination activity. This approach proved successful and led to the development of 
the most catalytically efficient computationally designed enzyme for the Kemp elimination to date 
(20).  
Among all the competing alternate states of proteins, domain-swapped dimers are common 
because they are often nearly identical to their monomeric counterparts (21). Frequently, they differ 
by only one or two mutations in the hinge region. Apparently, altering these residues can provide 
the conformational change needed for domain-swapped dimerization while keeping the rest of the 
protein intact. Studies have shown that mutating these critical residues can affect the domain-
swapping tendency significantly (22, 23).  
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Given that the domain-swapped dimer configuration is usually not modeled explicitly in 
single-state CPD calculations, it is not surprising that sequences that could assume this fold would 
be among those predicted, especially if the design involves alteration of loop residues. For example, 
Baker’s group used CPD to design the IgG-binding domain of protein L and inadvertently found 
that one of the point mutants (G55A) was a weak domain-swapped dimer with a dissociation 
constant (Kd) of ~30 µM (22). Similarly, while attempting to design a homodimer from the 
monomeric protein engrailed homeodomain (ENH), we generated an even higher affinity dimer (Kd 
~40 nM) that also proved to be domain-swapped when examined by X-ray crystallography.  
Comparison of the crystal structures of ENH and this dimer (named ENH_DsD) suggested that 
domain swapping might be initiated by opening the loop between two of its helices. We 
hypothesized that ENH_DsD’s ability to make this dramatic move would be reflected by unusually 
high backbone flexibility along the loop in the monomeric state, and that the wild-type protein 
(ENH), which does not adopt the domain-swapped configuration, would have significantly lower 
flexibility in this loop. We anticipated that these differences in loop dynamics might be observable 
in MD simulations of the two proteins, and set out to explore this possibility. As expected, short 20 
ns MD simulations revealed greater flexibility in this loop for ENH_DsD than for the wild type. 
Similarly, we reasoned that any mutations to ENH_DsD that caused the protein to recover the 
monomeric state would also be reflected in wild-type loop dynamics. Again, this proved to be the 
case — an ENH_DsD point mutant that showed wild-type loop dynamics was confirmed by X-ray 
crystallography to assume the wild-type monomeric fold. To determine the general applicability of 
our MD protocol, we also investigated two domain-swapped dimer mutants of the IgG-binding 
domain of protein L, and found that their hinge dynamics correlated with the strength of domain-
swapped dimerization.  
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Results and Discussion 
De Novo Homodimer Design Produced a Domain-Swapped Dimer (ENH_DsD).  Our original 
goal was to use computational tools to engineer a de novo homodimer from a monomeric protein. 
We docked two Drosophila melanogaster engrailed homeodomain monomers (PDB ID: 1ENH) (24) 
to form an in silico C2-symmetry homodimer (25), then used CPD to redesign the protein-protein 
interface to create affinity between the two identical chains. The oligomeric state(s) of the designed 
variants was determined using size exclusion chromatography and fluorescence polarization 
techniques.  To assist in these assays, a yellow fluorescent protein (YFP) (26) was fused to the C 
terminus of each of the designed sequences. Size exclusion chromatography revealed that one of the 
predicted sequences, ENH_DsD, elutes primarily as a dimer, with some contribution from higher 
oligomers (Fig. 2-1A). Fluorescence polarization was determined using the Förster resonance 
energy transfer (FRET) assay, which yielded a Kd of ~40 nM (Fig. 2-1B). The decreased 
polarization at higher concentrations is caused by the dimerization of ENH_DsD-YFP, in which 
two nearby YFPs transfer energy to each other (homo-FRET). Note that these assays cannot 
distinguish between a regular dimer (where each chain retains the wild-type monomeric fold) and a 
domain-swapped dimer. The only definitive way to make this distinction is to solve the structure, so 
we performed X-ray crystallography on ENH_DsD-YFP and resolved the structure to 1.85 Å (Fig. 
2-2A). Analysis revealed that a domain-swapped dimer formed between two ENH_DsD sequences 
(Fig. 2-2B). It appears that the hinge-loop between the first and second helices in the wild-type 
structure flipped over and coiled up. In the domain-swapped conformation, the first helix, the hinge, 
and the second helix thus form a single long helix (Fig. 2-2C). The rest of the structure essentially 
remains intact; i.e., excluding the hinge, superposition of ENH_DsD and wild-type engrailed gives 
a Cα RMSD of 0.57 Å (Fig. 2-2B). Note that ENH_DsD shares only 49% sequence identity with 
wild-type ENH (25 out of 51 residues). 
 
 
20 
Molecular Dynamics Suggests Increased Hinge Flexibility Is Associated with ENH_DsD’s 
Domain-Swapping Capability. Given our goal of engineering a regular homodimer, we were 
displeased to find that ENH_DsD is a domain-swapped dimer. Unfortunately, solving the structure 
of all promising dimer designs in order to verify that they retain the wild-type fold would be 
extremely time-consuming. We hoped to circumvent this laborious process by developing a 
computational method that could predict whether designed variants are domain-swapped or not.  
In the case of ENH_DsD, the hinge between helices 1 and 2 must be highly flexible to 
allow it to flip over ~90º and coil up to assume the domain-swapped dimer configuration. We 
hypothesized that flexibility in the hinge would be observable with MD, and that an MD simulation 
of the ENH_DsD sequence threaded onto the wild-type monomer structure would show unusually 
high hinge dynamics. However, any loop is intrinsically more flexible than secondary structure 
regions whether it is involved in domain swapping or not. A reference was therefore needed to 
define “unusually” high dynamics. We used the wild-type protein as our reference, because it is 
known to be a stable monomer that does not exhibit dramatic conformational changes. We ran 20 ns 
explicit water MD simulations on the wild-type protein and on the ENH_DsD sequence threaded 
onto the wild-type backbone structure, and for each trajectory calculated the backbone root mean 
square fluctuation (RMSF) for each Cα over the whole trajectory. Three trajectories were run for 
each sequence, and the average B factors were calculated and used as our metric of structural 
flexibility. As seen in Fig. 3A, nearly all the residues in the wild-type protein have very low B 
factors, except those close to the N and C termini. The B factors for the ENH_DsD residues are 
similar to wild type, except for those in the hinge, particularly residues 23 and 24, which are 
significantly higher (Fig. 2-3B). Unusually high flexibility in this hinge may thus be associated with 
ENH_DsD’s domain-swapping capability. It is entirely possible, however, that this enhanced hinge 
flexibility could instead reflect other physical phenomena, such as switching between multiple loop 
conformations. 
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ENH_DsD Mutant Designed to Recover Monomeric Fold Reverts to Wild-Type Hinge 
Flexibility. As mentioned above, if ENH_DsD’s domain-swapping capability is associated with 
enhanced flexibility in the hinge, we reasoned that mutations to ENH_DsD that cause the protein to 
recover the monomeric fold would also change its hinge dynamics back to wild-type. An obvious 
strategy for reverting ENH_DsD back to the wild-type structure is to put one or more prolines in the 
hinge. Steric conflict from the pyrrolidine ring in proline precludes residues directly N-terminal to it 
from adopting a helical structure. By discouraging helix formation in the hinge of the domain 
swapper, we hoped to shift the equilibrium so that the monomeric fold would again become the 
dominant state.  
Since prolines often occupy the first or second residue of α-helices (27), we substituted a 
proline into these positions on helix 2 of ENH_DsD to make two point mutants (E23P and E24P) 
and examined the dynamics of these sequences using the MD protocol described above. As seen in 
Fig. 2-3B and C, the B factors of the hinge residues in E23P are much lower than those in 
ENH_DsD; in fact, although the error bars are larger, E23P’s B factors are very similar to those of 
the wild type at all positions (Fig. 2-3A and C). These results suggest that the E23P sequence is 
dynamically stable in the wild-type conformation and less likely to switch to other conformations. 
In contrast, E24P resembles ENH_DsD in that it still has a very high B factor region that 
corresponds to the hinge-loop (Fig. 2-3B and D). Thus, the hinge dynamics obtained from MD 
show that E23P is wild-type-like, and thus probably a regular dimer, whereas E24P resembles 
ENH_DsD and is therefore more likely to form other competing states. The sequences of wild-type 
ENH, ENH_DsD, E23P, and E24P are listed in Table 2-1.  
Biophysical and Structural Analyses Support MD Predictions. We constructed the E23P-YFP 
and E24P-YFP proteins and examined their dimerization properties using the homo-FRET assay. 
E23P-YFP appears to be a strong dimer (Kd ~10 nM) (Fig. 2-4), but E24P-YFP shows no detectable 
dimerization in the low µM range (anisotropy >300 mA). The fact that E23P-YFP and E24P-YFP 
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differ in their oligomeric states is consistent with the MD data, and suggests that these two proteins 
adopt different conformations.  
To confirm our MD prediction that E23P is a regular dimer and not a domain-swapped 
dimer, we determined the structure of E23P-YFP to 2.3 Å using X-ray crystallography (Fig. 2-5A). 
Superposition of the wild-type (ENH) and E23P-YFP structures (Fig. 2-5B) clearly shows that the 
single proline mutation in E23P rescues the wild-type fold. The Cα RMSD for E23P vs. wild type is 
0.36 Å for the whole chain and 0.62 Å for the hinge-loop. The X-ray structure thus confirms that 
the dimerization observed by homo-FRET results from a regular dimer. Interestingly, the dimer is 
not formed as modeled in the initial CPD homodimer designs.  Instead of a single interface being 
formed by the two designed surfaces of the first and second helices, two interfaces are formed 
between each of the designed surfaces and a patch on YFP (Fig. 2-5A). This unexpected finding 
emphasizes that spurious results can occur when unwanted conformations are not specifically 
excluded by incorporating negative design into CPD.   
Protein L Mutants Test Applicability of MD Protocol. We also investigated two mutants of the 
B1 domain of protein L from Peptostreptococcus magnus generated by Baker’s group (22, 23). 
O’Neill et al. showed that the point mutant G55A is a weak domain-swapped dimer (Kd ~30 µM) 
(22). CPD was then used to stabilize this domain-swapped dimer structure, creating a triple mutant 
obligate dimer (Kd ~700 pM) (A52V/N53P/G55A) (23). We decided to take advantage of the large 
difference in dissociation constants exhibited by these mutants to test the applicability of our MD 
protocol. We therefore applied our MD method to three protein L sequences (wild type, G55A, and 
the triple mutant) to determine whether the backbone dynamics of the hinge reflects the protein’s 
domain-swapping tendency.  
Each of the three sequences was threaded onto the wild-type monomeric structure (PDB ID: 
1HZ5) (28) and the same MD protocol developed above was applied. Compared to wild-type ENH, 
wild-type protein L has a more flexible hinge region (Fig. 2-5A). This high dynamics is an intrinsic 
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property of the hinge-loop and does not necessarily reflect a domain-swapping capability. We used 
the wild-type again as our baseline for determining unusually high dynamics. As seen in Fig. 2-5B, 
the hinge dynamics of the weak domain-swapped dimer G55A are not significantly different from 
wild type. This result is not surprising, as G55A is a fairly stable monomer (2.6 kcal/mol) at 
concentrations under 10 µM. In contrast, the triple mutant shows a rather large change in hinge 
dynamics (Fig. 2-5C; B factor increases significantly at position 53), reflecting its strong domain-
swapping tendency (Kd ~700 pM).  
Table 2-2 summarizes the hinge B factors for each of the proteins tested, and compares 
these data with results obtained from X-ray crystallography, dimerization assays, and CPD 
calculations. First, note that domain swapping does not correlate with CPD energies. The domain-
swapped dimer ENH_DsD has a lower CPD energy (in the context of the monomer structure) than 
the regular dimer E23P, which prefers the monomeric state. This poor correlation is a direct result 
of failing to consider competing states in CPD. On the other hand, of the three experimentally 
validated domain-swapped proteins, the two stronger dimers (ENH_DsD and A52V/D53P/G55A) 
showed more flexibility in the hinge, as indicated by their MD-derived B factors. It appears that our 
MD method can identify domain-swapped dimers with Kd values in the nanomolar range or lower. 
However, this is a preliminary conclusion based on only three cases, and should be confirmed with 
further studies. The mechanisms underlying the dynamics of domain swapping are not well 
understood and may vary for different proteins. 
Molecular Dynamics as a Post-CPD Screening Method. CPD is a powerful tool for predicting 
sequences that may solve a given protein engineering problem. However, due to imperfections in 
CPD (e.g., inaccurate scoring function, fixed backbone approximation, discrete rotamer 
approximation, implicit water modeling, and lack of dynamics information) typically only a small 
portion of the top ranked sequences actually satisfy the design goals. The utility of CPD is thus 
critically dependent not only on the design strategy, but also on the experimental screening method 
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used to identify hits from the sequences predicted. Higher-throughput screens are obviously 
preferred, if available, as they have the distinct advantage of allowing larger libraries to be tested.    
MD simulations can serve as a complement to CPD and can help make up for some of its 
limitations. The continuous structure space of MD gives a much more accurate description of 
protein softness. The explicit inclusion of water is also a key feature for accurate protein modeling, 
especially for surface/pocket designs, such as loop designs, binder designs, or enzyme designs. 
More importantly, the trajectories provided by MD simulations provide time-related information 
that can be very informative. Several groups have thus used MD simulations as a post-CPD filter 
method for various engineering purposes. For example, Kiss et al. (19) used MD to evaluate and re-
rank variants obtained from de novo enzyme designs for the Kemp elimination reaction. Multiple 
analyses were developed as criteria for filtering the most promising designs. Among them, the 
dynamics of the system, instead of a single snapshot or an averaged structure, was used to evaluate 
enzyme activity. Key contacts between the protein sidechains and the substrate were monitored 
throughout the trajectory. Also, water accessibility in the active site pocket was analyzed, as water 
molecules are abundant and compete with the substrate. Overall, active designs could be clearly 
distinguished from inactive ones in 20 of the 23 cases tested. This is an impressive improvement 
over the success rate of CPD alone (8/59). However, as in our studies, their MD protocol was less 
successful in identifying marginally active enzymes. Privett et al. used a similar MD protocol to 
suggest a point mutant that resulted in a 3-fold improvement in Kemp elimination activity (20). 
Liang et al. also reported studies in which MD simulations were used to validate designs 
(29). They showed that the stability of a designed complex containing a computationally-grafted 
binding epitope could be visualized by the MD trajectory. Although their root means square 
analysis requires a much longer MD simulation time (~400 ns), it is conceptually similar to our 
RMSF protocol. Again, this study emphasizes the importance of protein dynamics—whereas MD 
analysis was able to distinguish stable protein complexes from unstable ones, monomer-dimer ΔG 
values calculated from static structures could not. Although their engineering goals were different, 
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the similarity between Liang’s and our methods indicates that analysis of MD-generated dynamics 
information can be a sensitive metric for evaluating the effects of even small perturbations in 
proteins. We expect that our MD protocol, which monitors backbone dynamics, will be especially 
useful, given that for most CPD engineering projects, the predicted variants must assume the correct 
fold in order to meet the design goals.  
The MD protocol proposed here can efficiently examine the fast backbone dynamics of 
proteins. A 20 ns trajectory of a small 50–60-residue protein such as ENH or protein L can be run in 
one day on a modern 8-CPU node with a parallelizable MD package such as GROMACS (30). Our 
protocol, however, is only applicable for fast dynamics (i.e., in the nanosecond range). The 
dynamics of many other events (e.g., protein-protein association or dissociation) occur on much 
longer time scales (from microseconds to seconds). In these cases, either a longer trajectory, such as 
that employed in Liang’s work, or a different, more efficient type of MD (e.g., coarse-grained 
models or steered MD) might be required to identify good designs. Significant effort has been 
applied to generate ultra-long MD simulations so that events with slower dynamics, such as protein 
folding, can be studied (31). We anticipate that as MD techniques continue to improve, the utility of 
MD as a post-CPD screening tool will expand and become more prevalent.      
Conclusions 
In this work, we present a simple MD protocol for evaluating the domain-swapping tendency of 
CPD-designed protein variants. The protocol consists of a 20 ns MD simulation of the designed 
sequence, followed by RMSF analyses of the backbone atoms. By applying this protocol to the 
domain-swapped dimer ENH_DsD, we found unusually high flexibility in the hinge-loop compared 
to that of the monomeric wild-type protein. To recover the wild-type fold, two mutants, E23P and 
E24P, were made and examined using our MD protocol. E23P exhibited wild-type-like backbone 
dynamics and was therefore predicted to revert to the wild-type fold. Resolution of the structure by 
X-ray crystallography confirmed the MD prediction. We tested the applicability of our method on 
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CPD–designed variants of the B1 domain of protein L, and similarly found that domain-swapping 
tendency correlated with flexibility in the hinge region. We anticipate that our MD protocol can be 
used as an in silico post-CPD filter, which may circumvent the need for time-consuming structural 
studies and will be most useful when experimental screening techniques are not adequate.    
Materials and Methods 
Construct Preparation, Expression, and Purification. Oligonucleotides (Integrated DNA 
Technologies) containing ~20 bp overlapping segments were assembled via a modified Stemmer 
polymerase chain reaction (PCR) method using KOD Hot Start Polymerase (Novagen) to generate 
the full-length designed sequence ENH_DsD (Table S1). The PCR product and YFP gene (26) with 
a C-terminal His6 tag at the 3 " end were fused using overlap extension PCR. The ENH_DsD-YFP 
gene was then cloned into pET-11a using standard digestion/ligation methods. The E23P and E24P 
mutants were created by standard quick-change protocols. The plasmids were transformed into 
Escherichia coli BL21(DE3) cells; colonies were picked, and the plasmids miniprepped and 
sequenced. Sequence-verified constructs were expressed in standard Luria Broth at 37ºC using 1 
mM isopropyl β-D-1-thiogalactopyanoside (IPTG) for 3 h. The cells were centrifuge harvested and 
sonication lysed. The target protein was purified by Ni2+-NTA (Qiagen) column. 
Size-Exclusion Chromatography. Size-exclusion chromatography was carried out at room 
temperature using an analytical Superdex-75 column (Amersham Pharmacia). After affinity column 
purification, each sample was loaded on an ÄKTA FPLC system with 0.5 mL sample volume, and 
run at 0.5 mL/min flow rate with running buffer (100 mM NaCl and 20 mM Tris-HCl, pH 8.0). 
Absorbance at A515 (absorbance peak for YFP) was tracked for protein elution. Typically, >10 mg 
protein/L cell culture was purified for each construct.      
Polarization Fluorescence Assay. The polarization fluorescence was measured at room 
temperature with a Fluorolog-3 spectrofluorometer (HORIBA). ENH_DsD-YFP was serially 
diluted in buffer containing 100 mM NaCl and 20 mM TrisHCl at pH 8.0. The fluorescence 
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anisotropy was measured for each sample, and the G-factor was determined individually. The data 
were analyzed according to a simple monomer-dimer equilibrium model and fit with KaleidaGraph 
software. The anisotropy values (mA) for the completely monomeric and dimeric states were fit to 
be 260 and 330, respectively.  
Crystallography. The ENH_DsD-YFP crystal was grown in 0.8 M monosodium phosphate, 1.2 M 
dipotassium phosphate, and 0.1 M sodium acetate at pH 4.5 using hanging-drop diffusion. The 
E23P-YFP crystal was grown in 0.1 M sodium chloride, 0.1 M 12% v/v/ 2-propanol, and 0.1 M 
sodium acetate at pH 4.6 using hanging-drop diffusion. Crystals were flash frozen in glycerol 
cryoprotectant and shipped to beamline 12-2 at Stanford Synchrotron Radiation Lightsource. Phases 
were obtained through molecular replacement using YFP as a model (PDB:1MYW) (26). 
Following molecular replacement, the ENH_DsD and E23P residues were built manually into the 
electron density map using COOT (32), respectively. Further refinement was done by PHENIX 
(33). Final coordinates were deposited in the Protein Data Bank with the codes 4NDJ (ENH_DsD-
YFP) and 4NDK (E23P-YFP). Data collection and refinement statistics are listed in Tables 2-3 and 
2-4.  
MD Simulations. The input structures for the MD simulations were prepared as follows: 1ENH 
and 1HZ5 were used as the template backbone structures for the engrailed homeodomain and IgG-
binding domain of protein L sequences, respectively. Sequences were first threaded onto the 
corresponding backbone structure and side-chain repacking optimization was applied. The structure 
was then input to GROMACS 4.5.5 for energy minimization (GROMOS 43a1) with an explicit 
water box under periodic boundary conditions (30). If there were any extra charges on the protein, 
they were neutralized by adding sodium or chloride ions. After energy minimization converged to 
Fmax < 1000 kJ/mol, a 20 ps position-restrained MD simulation was run for water relaxation at 300 
K with 2 fs steps. Finally, a 20 ns unrestrained MD was run at 300 K under NPT conditions. The 
RMSF of Cα atoms was analyzed by g_rmsf built in GROMACS for the whole 20 ns trajectory. A 
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total of three trajectories with different random seeds was run for each sequence and the averaged B 
factors ware calculated using the following equation: B = (8π2/3) × (RMSF)2, where the RMSF 
units are Å. 
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Table 2-1.  Sequences of wild-type ENH, ENH_DsD, E23P, and E24P 
 
 
ENH(WT) TAFSSEQLARLKREFNENRYLTERRRQQLSSELGLNEAQIKIWFQNKRAKI 
ENH_DsD -E--E--KKA-DLA-YFD-R---EW-RY--QR-----E--ER--RR-EQQ- 
E23P -E--E--KKA-DLA-YFD-R--PEW-RY--QR-----E--ER--RR-EQQ- 
E24P -E--E--KKA-DLA-YFD-R---PW-RY--QR-----E--ER--RR-EQQ- 
The three “coils” at the top show the location of the three helices in the wild-type (WT) fold. 
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Table 2-2. Summary of X-ray crystallography, dimerization assays, CPD calculations, and 
MD-derived hinge B factors for each of the proteins tested.  
 Domain-
Swapping 
Kd*    CPD energy† 
 
      B-factor‡ 
 
 
 
ENH (WT) No n/a -127.0 21.1 
ENH_DsD Yes 40nM -125.2 70.9 
E23P No n/a -123.7 32.7 
E24P n/a n/a -120.6 106.6 
1HZ5 (WT) No n/a -183.1 78.4 
G55A Yes 30uM -166.2 58.2 
A52V/D53P/G55A Yes 700pm 249.1 179.6 
 
*Dissociation constant for the domain-swapping dimer. 
†CPD energy was calculated in the context of the monomer structure. 
‡The maximal B-factor on the hinge. 
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Table 2-3. Data collection and refinement statistics for the crystal structure of ENH_DsD-
YFP (PDB: 4NDJ) 
Statistics Value 
Data collection  
    Space group P4222 
    Cell dimensions  
        a, b, c (Å) 104.4, 104.4, 80.2 
        α, β, γ (°) 90.0, 90.0, 90.0 
    Resolution (Å) 30−1.85 
    Rmerge 0.052 
    I/σ 20.2 
    Completeness, % 99.2 
    Multiplicity 7.3 
Refinement  
    Resolution (Å) 30−1.85 
    Number of reflections  39983 
    Rwork/Rfree (%) 17/20 
    Number of molecules in asymmetric unit 1 
    Number of atoms 
        Protein 
        Water 
        Ligands 
2627 
2275 
333 
19 
   B factors (Å2) 
       Protein 
       Water 
       Ligands 
31.2 
29.7 
42.0 
21.3 
    R.m.s. deviations 
    Bond lengths (Å) 
    Bond angles (°) 
 
0.007 
1.16 
    Ramachandron map analysis  
        Most favored regions (%) 
        Additional allowed regions (%) 
        Disallowed regions 
 
98.9% 
1.1% 
0% 
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Table 2-4.  Data collection and refinement statistics for the crystal structure of E23P-YFP 
(PDB: 4NDK) 
Statistics Value 
Data collection  
    Space group P2221 
    Cell dimensions  
        a, b, c (Å) 75.9, 192.7, 107.6 
        α, β, γ (°) 90.0, 90.0, 90.0 
    Resolution (Å) 34−2.3 
    Rmerge 0.064 
    I/σ 8.3 
    Completeness, % 99.4 
    Multiplicity 4.0 
Refinement  
    Resolution (Å) 34-2.3 
    Number of reflections  35208 
    Rwork/Rfree (%) 19/24 
    Number of molecules in asymmetric unit 2 
    Number of atoms 
        Protein 
        Water 
        Ligands 
4848 
4416 
394 
38 
   B factors (Å2) 
       Protein 
       Water 
       Ligands 
35.0 
34.9 
36.6 
24.5 
    R.m.s. deviations 
    Bond lengths (Å) 
    Bond angles (°) 
 
0.008 
1.15 
    Ramachandron map analysis  
        Most favored regions (%) 
        Additional allowed regions (%) 
        Disallowed regions 
 
96.4% 
3.4% 
0.2% 
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Fig. 2-1.  Size exclusion and polarization fluorescence assays indicate that ENH_DsD-YFP is a 
high-affinity dimer. (A) Size-exclusion chromatography for ENH_DsD-YFP (black) and a 
monomeric control, UVF-YFP (gray). Absorbance at A515 (absorbance peak for YFP) was tracked 
for protein elution. UVF is a computationally designed 39-fold mutant of ENH whose NMR 
solution structure matches the wild-type (monomeric) fold (34). The retention volumes for UVF-
YFP and ENH_DsD-YFP are consistent with standards for a monomer and a dimer, respectively. (B) 
Polarization fluorescence of ENH_DsD-YFP. The unit of anisotropy (mA) is a thousandth of 
anisotropy (A). A Kd of ~40 nM was calculated based on a simple monomer-dimer equilibrium 
model. 
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Fig. 2-2. X-ray crystallography reveals that ENH_DsD-YFP is a domain-swapped dimer. (A) 
Crystal structure of ENH_DsD-YFP resolved to 1.85 Å. The two chains in ENH_DsD are shown in 
green and cyan, respectively, and the YFP sequences are shown in gray. (B) Zoom-in of the dashed 
frame in A with the wild-type ENH structure (PDB ID: 1ENH) (gray) superimposed. (C) The hinge-
loop between the first and second helices in the wild-type structure (gray) has flipped over by ~90º 
(arrow) and coiled up to form the domain-swapped conformation seen in ENH_DsD-YFP (cyan). 
This change leads to a ~180º rearrangement of helix 2 so that helix 1, the hinge, and helix 2 now 
form a single long helix. 
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Fig. 2-3.  B factor analyses from MD simulations for wild-type ENH (A), ENH_DsD (B), E23P (C), 
and E24P (D). 20 ns MD simulations were run on wild-type ENH and on each of the variant 
sequences threaded onto the wild-type backbone structure, the RMSF of the Cα atoms was analyzed 
using GROMACS for each of three trajectories, and the averaged B factors were calculated. Error 
bars: SD for three independent trajectories. Hinge residues (between helices 1 and 2 in wild-type 
ENH) are indicated with a gray bar in each panel. 
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Fig. 2-4. Polarization fluorescence indicates that E23P-YFP is a high-affinity dimer. Polarization 
fluorescence of E23P-YFP was measured with a series of diluted samples in buffer containing 100 
mM NaCl and 20 mM TrisHCl at pH 8.0. The unit of anisotropy (mA) is a thousandth of anisotropy 
(A). The G-factor was determined for each data point. A Kd of ~10 nM was calculated based on a 
simple monomer-dimer equilibrium model. 
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Fig. 2-5. X-ray crystallography of E23P-YFP shows that a single proline mutation in the hinge 
recovers the wild-type fold. (A) Crystal structure of E23P-YFP resolved to 2.3 Å. The E23P 
sequence is shown in green and cyan (for each of the two chains, respectively) and the YFP 
sequences are shown in gray. (B) Zoom-in of the dashed frame in A with the wild-type ENH 
structure (gray) superimposed. E23P exhibits the wild-type fold. 
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Fig. 2-6.  B factor analyses from MD simulations for the B1 domain of protein L (wild-type) (A), 
G55A (B), and the triple mutant A52V/D53P/G55A (C). For G55A and the triple mutant, sequences 
were first threaded onto the wild-type monomeric structure. As described above, 20 ns MD 
simulations were run, the RMSF of the Cα atoms was analyzed using GROMACS for each of three 
trajectories, and the averaged B factors were calculated (see Methods for details). Error bars: SD for 
three independent trajectories. Hinge residues are indicated with a gray bar in each panel. The 
backbone dynamics of the hinge varies for the different proteins and reflects their domain-swapping 
tendencies. 
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Chapter 3 
Computational Design and Experimental Verification of 
a Symmetric Homodimer 
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Abstract  
Homodimers are by far the most common type of protein assembly in nature and have distinct 
features compared to heterodimers and higher-order oligomers. Understanding homodimer 
interactions at the atomic level is critical both for accurate modeling and for elucidating their 
biological mechanisms of action. Computational design of novel protein-protein interfaces can 
serve as a bottom-up method to further our understanding of protein interactions. Previous studies 
have demonstrated that the de novo design of homodimers can be achieved to atomic-level accuracy 
by ß-strand assembly or metal mediation. Here, we report a novel homodimer with C2 symmetry 
that is designed via helical interactions. The structure obtained by solution nuclear magnetic 
resonance shows that the homodimer exhibits parallel helical packing similar to the designed model. 
Because designing for improved functionality often results in decreased thermostability, a stability 
design step was introduced. in addition to our standard docking and design procedure, to 
compensate for the poor thermostability of the scaffold. This two-step design approach is essential 
when a thermophilic protein is not available or desirable as the scaffold for design. 
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Introduction 
Protein-protein interactions play a central role in nearly all biological processes, including cell 
signaling, immune responses, regulation of transcription and translation, and cell-cell adhesion. 
Improving our understanding of protein-protein interactions is therefore crucial to advancements in 
both basic and applied research in the pharmaceutical, chemical, and biotechnology industries. The 
influx of structures deposited into the Protein Data Bank (PDB) during the last two decades has 
helped researchers identify unique features of protein-protein interactions (1-3). Specific interfacial 
residues that contribute to most of the binding energy (“hot spots”), networks of hydrogen bonds, 
and shape complementarity have all been identified as important. These features have therefore 
been incorporated into many protein docking and protein design algorithms (4, 5). Protein docking 
algorithms have successfully been used to screen millions of docking positions and identify the 
correct (near-native) structure (6). Computational design tools have also exploited our knowledge of 
protein-protein interactions to successfully design enhanced affinity or altered specificity (7, 8), to 
graft binding motifs onto a desired scaffold (9, 10), and to create novel interfaces (11-16). Several 
studies have shown the atomic-level accuracy of de novo designed protein dimers.  However, the 
success rate of novel interface designs is rather low (17) and remains one of the most challenging 
areas in the field (18). 
Homodimers are by far the most common type of protein assembly and are well 
represented in the PDB. Compared to heterodimers, homodimers have larger surface area, fewer 
hydrogen bonds, higher hydrophobicity, and typically, C2 symmetry (19). Although homodimers 
are abundant in nature, there are only a few examples of the computational design of symmetric 
homodimers. Stranges et al. showed that solvent-exposed β-strands can be used as anchors to design 
a symmetric homodimer that associates via β-strand pairing (16). Der et al. incorporated metal 
binding sites to drive homodimerization and achieve high affinity and orientation specificity (13). 
Interestingly, in their study, the helices on each side of the metal-mediated homodimer interface 
aligned nearly orthogonally, unlike the parallel or anti-parallel alignments of helices typically found 
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in nature. Both parallel and anti-parallel coiled-coil like dimers have been designed using short 
peptides (20, 21). However, there have been no structurally verified homodimers designed via novel 
helical interfaces between proteins. Helical interactions, often in the form of coiled-coils, occur 
twice as frequently at homodimer interfaces (22.4%) compared to heterodimer interfaces (10.9%), 
but strand-strand interactions are seen at about the same frequency (8.8% and 8.4%, respectively) 
(22). We were therefore very interested to see whether we could computationally design a helical 
interface on a monomeric globular protein that facilitates homodimerization with C2 symmetry. 
Designing a homodimer by helical interactions presents many challenges. First, unlike 
strand-strand interactions, where association occurs via specific backbone hydrogen bonds, the 
helical interface does not provide chemically specific anchors for protein-protein interactions. 
Although there are some empirical rules for archetypal coiled-coil oligomerization (23), a general 
sequence-structure relationship that could be applied to any arbitrary scaffold has not yet been 
found. Moreover, high-throughput methods for identifying protein-protein interactions (e.g., yeast 
display) cannot be used for homodimer screening, as heterodimers will dominate a library. 
Furthermore, as shown by Keating and co-workers, predicting parallel or anti-parallel helix-helix 
homodimers using computational modeling is not trivial (24). The similarity between parallel and 
anti-parallel helix-helix structures and the high hydrophobicity of homodimers make it difficult to 
distinguish between the different conformational states, particularly if they are strongly competing 
with each other and only one of the states is explicitly designed. For example, Karanicolas et al. 
computationally designed a novel protein-protein interface with tightly packed hydrophobic 
residues (25). The crystal structure, however, revealed that the orientation of one of the partners was 
rotated almost 180° relative to its position in the design model. These results underscore the 
difficulty of excluding unwanted competing states in the design of protein-protein interactions.  
Here, we design a C2-symmetry homodimer from a helical monomeric protein, Drosophila 
melanogaster engrailed homeodomain (ENH). This small helix-turn-helix protein binds a specific 
sequence of double-stranded DNA (dsDNA) (26), and has been used as a model for many 
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theoretical and computational studies (27-29). Computational protein design (CPD) projects often 
begin with a highly thermostable scaffold, because designs for improved function (e.g., catalytic 
activity, ligand-protein binding affinity) can decrease protein stability significantly (30). Poor 
stability in turn often results in aggregation and can be problematic for recombinant expression 
and/or experimental characterization. Wild-type ENH has a low melting temperature (Tm) of 49°C 
(31). Indeed, we found that interface design of wild-type ENH led to a protein (ENH-c2a) that 
expresses in inclusion bodies even at reduced temperatures. We then  incorporated mutations from 
Marshall et al. (31) that achieved improved thermostability (an ENH variant called NC3-NCap with 
Tm = 89°C) for later designs. We applied a symmetrical docking program based on a fast Fourier 
transform algorithm (32) and designed the interface between four helices (two from each molecule) 
so they would associate as a four-helix bundle. The final design (ENH-c2b) was experimentally 
characterized as a monodisperse homodimer with a Kd of ~130 nM. The solution nuclear magnetic 
resonance (NMR) structure reveals that the helical interface exhibits parallel packing, as designed in 
our model. 
Results 
Scaffold Selection. Due to our incomplete understanding of structure-function relationships and 
limitations in our ability to accurately model proteins, the success rate for computational protein 
design is rather low. This is particularly true for the de novo design of functional proteins such as 
enzymes with novel catalytic activity or proteins designed to interact with a specific target (33). 
Many de novo design studies therefore use a comprehensive approach that virtually screens all 
favorable scaffolds in the PDB, often resulting in tens to hundreds of candidate scaffolds (11, 16, 34, 
35). These candidates are then screened experimentally (e.g., for target binding affinity, catalytic 
activity). This approach has the advantage of providing a large amount of data that can be used to 
test design protocols (18, 36). However, it usually relies on a general design strategy, which may 
not be optimal for any particular scaffold. Alternatively, using a single scaffold allows the design to 
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take specific features of the scaffold into account. For example, Privett et al. used an iterative 
approach on a single scaffold that resulted in the de novo design of the most efficient Kemp 
eliminase to date (30). Scaffold properties such as the hydrophobicity of the active site pocket and 
substrate packing were taken into account in second and third generation designs, yielding 
improved enzyme variants. Choosing a particular scaffold may also be desirable if one is interested 
in certain native properties of the protein that are crucial to one’s ultimate design goals. We chose 
ENH, for instance, for its DNA-binding properties, which would facilitate our final goal of creating 
a protein that can loop DNA or form a protein-DNA nanoparticle. The co-crystal structure of ENH 
and its target DNA shows that this scaffold can allow for homodimer design while retaining its 
DNA-binding capability. The third helix (helix-3) is the major DNA binding domain. The first and 
second helices (helix-1 and helix-2) are not in contact with the DNA (26), and expose a large flat 
surface that is potentially appropriate for designing a homodimer interface via helical interactions. 
ENH was therefore chosen as our single starting scaffold for docking and homodimer design.  
Design Protocol. Fig. 3-1 shows the steps we used to design and characterize a C2-symmetrical 
homodimer. After selecting the scaffold protein, the surface sidechains were pruned to Cβ and the 
atomic radii were parameterized based on known C2 symmetry homodimers. We then applied a 
symmetrical docking program that we had developed based on a fast Fourier transform (FFT) 
algorithm (32). FFT docking allowed us to efficiently search all six translational and rotational 
docking positions. About 1010 docking positions were screened and ranked by shape 
complementarity. The top 200 candidates were clustered into 11 groups according to the root-mean-
squared deviations (RMSDs) of the structures. Finally, these clusters were visually inspected and 
one model was chosen for homodimer design. In this homodimer model, the two helix-1’s (one 
from each subunit) form parallel helix-helix packing and are separated by 10 Å, similar to the 9.8 Å 
separation found in naturally occurring coiled-coil dimers (37). Note that our design process did not 
explicitly use the heptad repeat rules that govern coiled-coil interactions (20); the designed interface 
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is determined by the physical-chemical interactions specified by the force field. The two helix-2’s in 
the dimer are on opposite sides of the two helices 1 (one on each side). Together, helix-1 and helix-
2 from the two subunits form a four-helix bundle structure (see bronze model, Fig. 3-1).  
Next, symmetrical sequence optimizations were applied to the interfacial residues of the 
homodimer model. To mimic natural homodimers, which have relatively high hydrophobicity at the 
interface (~65%) (19), the balance between polar and non-polar amino acids was carefully 
monitored during sequence optimization. In the force field used for our optimizations, the energy 
term that is predominantly responsible for hydrophobicity is the solvation energy (38): !!" = !!"!!",! + !!"!!",! + !!!!,! , 
where the atomic solvation energy (Eas) consists of a benefit term for burial of nonpolar amino acids 
(!!"!!",!) and penalty terms for non-polar amino acid exposure (!!"!!",!) and polar amino acid 
burial (!!!!,!). Each of these terms contains a solvation energy factor (σ) and a surface area 
component (A). The value of σp specifies the magnitude of the penalty for burying polar atoms. By 
adjusting this factor, we fine-tuned the hydrophobicity of the designed interface to be as close to 
natural homodimers as possible. The final value of σp for our model was determined to be 0.04, 
raised by 0.02 from its standard value.  
Homodimer design was first done using wild-type ENH as our starting scaffold. 
Unfortunately, the resulting protein (ENH-c2a) could only be expressed in inclusion bodies (Fig. 3-
2) so we repeated the interface design using a thermostabilized variant of ENH that had been 
generated previously (NC3-NCap) (31) (the NC3-NCap sequence was threaded onto the docked 
homodimer model). We expected that this more stable protein would result in designed sequences 
with improved soluble expression. In order to examine the top designed sequences in a high-
throughput manner, a computational library consisting of 128 variants of NC3-NCap was generated 
(Table 3-1), fused to YFP, and screened using a homo Förster resonance energy transfer (FRET) 
assay (Fig. 3-3A). Two representative high-affinity variants resulting from the screen were 
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characterized via size exclusion chromatography and sedimentation velocity experiments; one 
proved to be a dimer, and the other was a tetramer (Fig. 3-3B and C). In Chapter 2, we showed that 
the dimer is domain-swapped (ENH_DsD), and that we could revert it to the wild-type monomeric 
fold by substituting residue 23 with a proline, thereby decreasing hinge flexibility. The resulting 
sequence (ENH-c2b) expressed well in the soluble fraction. The sequences of the two homodimer 
designs (ENH-c2a and ENH-c2b) and their starting scaffolds (ENH and NC3-NCap, respectively) 
are listed in Table 3-2.  
Biophysical Characterization of ENH-c2b. The designed proteins were characterized for soluble 
expression, secondary structure, thermostability, and oligomeric state. SDS-PAGE gels of purified 
ENH, ENH-c2a, and ENH-c2b are shown in Fig. 3-2. Although ENH could be expressed in the 
soluble fraction at 16°C, ENH-c2a showed no soluble expression under the same conditions. In 
contrast, ENH-c2b expressed well at 37°C, with yields of over 5 mg per liter culture. Circular 
dichroism (CD) spectroscopy revealed that ENH-c2b is a helical protein with a perfectly reversible 
denaturing curve that has a Tm of ~62°C (Fig. 3-4A and B). The designed interface reduced the Tm 
by ~26°C from 88°C, which is the Tm of the starting scaffold (NC3-NCap). The much lower 
thermostability of the starting scaffold used to generate ENH-c2a (ENH, Tm = 49°C) might explain 
why this protein failed to be solubly expressed.  
Size-exclusion chromatography of ENH-c2b showed fast reversible equilibrium between 
the monomeric and dimeric forms (Fig. 3-5A). The elution peak occured earlier with high 
concentration loading (14 mL) than with low loading (16 mL). Using standard elution profiles, we 
assigned the elution peaks at 14 and 16 mL as the dimeric (~13 kD) and monomeric states (~6.5 
kD), respectively. Sedimentation velocity experiments showed that ENH-c2b is a monodisperse 
dimer at 5 µM concentration (Fig. 3-5B), which implies that the Kd is in the sub-µM range or lower. 
The Kd was determined using a tryptophan fluorescence-based homo-FRET assay, and was found to 
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be 129 ± 64 nM (Fig. 3-5C), which is similar to the Kd values reported for other de novo protein 
interface designs (pre-affinity maturation) (11, 13, 16).  
Structural Determination of ENH-c2b. Extensive trials failed to generate high-quality crystals of 
ENH-c2b for X-ray diffraction. However, we did obtain a crystal structure of a variant that included 
an extra 21 residues at the N-terminus, but it turned out to be monomeric, as determined by PISA 
(39) (see Fig. 3-6). Next, we attempted to solve the structure of ENH-c2b using solution NMR. 
Heteronuclear single quantum coherence (HSQC) of freshly-prepared ENH-c2b showed a well-
folded protein with sharp peaks, but the peaks broadened over time. Adding a glycine and an 8-
residue StrepTag II at the C-terminus of ENH-c2b (ENH-c2b-Strep) greatly enhanced its long-
term stability. We were able to unambiguously assign chemical shifts to almost all of the backbone 
nuclei. However, peaks were missing for residues 21-23 (FYF) at the end of helix-1. This is 
consistent with the fact that the chemical shifts of aromatic residues are highly sensitive to their 
sidechain conformations, and can be easily broadened if multiple conformations exchange quickly.  
We determined the structure of the ENH-c2b-Strep homodimer using ψ/φ angle, hydrogen-
bond, Nuclear Overhauser Effect (NOE), and C2-symmetry restraints (Fig. 3-7, green structure). 
Final coordinates were deposited in the PDB with code 2MG4. Each monomeric subunit is 
superimposable with wild-type ENH except for the long loop between helices 1 and 2, residues 21-
23 (at the end of helix-1), and the N termini (Fig. 3-7A and B). Restraints are lacking for these 
regions, so they appear disordered in the NMR ensemble. Note that the interface helices (helix-1 
and helix-2) align almost perfectly with the design model (Fig. 3-7A). However, the orientation of 
helix-3 deviates slightly from that of the model (Fig. 3-7B). Compared to ENH, the rigid fragments 
of ENH-c2b-Strep (helices 1, 2, and 3, and the loop between helix-2 and helix-3) are very similar 
(backbone RMSD = 1.35 Å). Note that the sequence identity between ENH-c2b and ENH is only 
47%. 
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The solution structure of the ENH-c2b-Strep dimer shows parallel helix-helix packing 
between helix-1 of each subunit, as in our homodimer model. Compared to our model, the 
backbone RMSD of the rigid fragments is 2.23 Å (Fig. 3-7C and D). The axial orientations of the 
four helices (helices 1 and 2 from each of subunits) are nearly identical with those in the model (Fig. 
3-7C). The interface area is 2189 Å2, which falls in the range of natural single-patch homodimers 
(2740 ± 1240 Å2) (19). Nonpolar residues constitute 62% of the interface, which is very close to the 
average value of 65% for natural homodimers (19). A NOESY experiment designed to retain only 
inter-molecular interactions revealed several nonpolar interfacial residues that are likely to be 
important for dimerization, including Ala16, Leu19, Ala20, and Leu39 (Fig. 3-8). Structural 
alignment of only one of the subunits emphasizes that there are some differences from the model 
(Fig. 3-7E and F). These variations are expected given that the main driving force for dimerization 
in our design was hydrophobic interactions, which are less specific than other interactions.  
Discussion 
Stranges et al. recently reviewed the computational design of novel protein-protein 
interfaces and pointed out the challenges that this burgeoning field faces (17). Of 147 protein-
protein interaction designs, only four were confirmed successful by X-ray crystallography (i.e., the 
solved structure matched the design model). All the successful designs shared some common 
features—they exhibited fewer polar atoms (< 40%) and fewer buried hydrogen bonds at the 
designed interface than those seen in the failed designs.  This reduced number of buried hydrogen 
bonds in the successful designs is in contrast to what is typically observed in natural dimers. Our 
homodimer design showed similar results (62% nonpolar atoms and no buried H-bonds at the 
interface). This higher interfacial hydrophobicity is expected given that three of the five successful 
cases (including ours) were designs for homodimers (13, 16), which naturally exhibit high nonpolar 
content at the interface. In our case, we purposely biased the interface to replicate this naturally high 
nonpolar content by adjusting the solvation energy term. The other two successful cases 
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(heterodimer designs) also exhibited high interfacial hydrophobicity, probably because the targeted 
surface, the stem region of influenza hemagglutinin (HA), is a highly hydrophobic patch (11, 15).  
Hydrophobic surfaces alone often confer little specificity.  For example, the designed protein could 
bind to the target protein in the wrong orientation (25) or bind to itself to form undesired oligomers 
(11). Nonetheless, the design of protein-protein interfaces via hydrophobic interactions has led to 
successful results, whereas the successful design of polar interfaces still eludes us. Thus far, there 
are few reports of protein-protein interactions designed via hydrophilic interfaces. Very recently, 
Procko et al. designed a protein inhibitor that binds to a hydrophilic patch on lysozyme with high 
affinity; however, this complex has yet to be structurally validated (40).  
Another interesting feature of all five successful designs is that the designed interfaces 
mainly involve secondary structures. Both of the successful HA heterodimer designs described 
above have hot spots on their helices that bind to helical structures on the target HA stem. Of the 
three successful homodimer designs to date, one is between two helices (this work), one involves 
metal-protein interactions on the helices (13), and one uses two exposed β-strands to form the 
homodimer (16). Loops can also be exploited in protein-protein interactions, as demonstrated by the 
widespread use of loops in antibody-antigen interactions. Many computational loop designs have 
been attempted, but thus far, none have resulted in dimerization (11). In a community-wide 
assessment of protein-protein designs, Haliloglu and coworkers found that many of the failed 
designs contain more loops and turns than the successful ones, and the higher flexibility of these 
structures makes adopting a particular designed conformation difficult (18). Non-interfacial loop 
designs have occasionally proved successful (41-43). However, the design of interfaces involving 
loops appears to be more challenging, as the recognition-induced conformational changes that loops 
undergo upon association with another protein are still poorly understood and poorly modeled. 
Given these results, we suggest that future computational protein-protein designs include an in 
silico screening step that eliminates docked dimer models in which loops make up a significant 
portion of the interface.  
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One difference between our design and the four successful designs reported previously is 
that the accuracy of our design is somewhat lower than the others (RMSD for our design = 2.23 Å, 
whereas that for the other designs ranged from 1.0 to 1.8 Å). The success of the four more accurate 
designs may be due to their incorporation of specific hot-spot residues or anchoring interactions that 
steered the formation of a high-affinity dimer. For example, the two HA heterodimer designs used 
pre-defined hot-spot residues to match the specified locations on the target patch (11), and the 
homodimer design employed β-strand hydrogen bonds (16) or metal chelators to anchor the 
homodimerization (13). All of these designs exploited very specific pair-wise interactions to 
facilitate and guide complex formation. In addition, they also incorporated relaxation into the design 
processs to fine-tune docking positions. Although our design used a fixed backbone for sequence 
optimization and did not specify hot spots to orient docking, we still obtained a homodimer that 
matched our model relatively well. 
This work presents a CPD approach in which the stability and the functionality of the 
protein are taken into account in a stepwise fashion. Conventionally, CPD uses protein scaffolds 
with known structures for sequence designs. Here, we initially used wild-type ENH for homodimer 
design, but the resultant protein (ENH-c2a) could not be solubly expressed.  We then decided to use 
a thermostabilized variant of ENH (NC3-NCap) as our starting scaffold. Although NC3-NCap 
showed satisfactory properties, including improved thermostability, and secondary structure similar 
to wild-type ENH, its three-dimensional structure has not yet been confirmed by X-ray 
crystallography or NMR. Nevertheless, we modeled NC3-NCap using the wild-type ENH fold and 
proceeded with the interface design. Encouragingly, our resultant protein, ENH-c2b, proved to be 
homodimeric, as designed, and was shown by NMR to share the same fold as its parent ENH. Thus, 
in this case, stability design apparently facilitated the successful functional design of a homodimer. 
This “two-step” design approach is illustrated in Fig. 3-9. During the last decade, CPD has proved 
to be very powerful for designing proteins with improved stability (44, 45). Recently, the field has 
moved to include the design of functionality, such as new or improved catalytic activity, binding 
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affinity, ligand or substrate specificity, etc.  Functionality design can, however, destabilize a protein 
significantly (30). In the worst-case scenario, the designed protein variants cannot be solubly 
expressed. For example, Fleishman et al. designed 88 proteins to bind to HA and found that 50% of 
them could not be solubly expressed in Escherichia coli (5). In our work here with ENH, we 
showed that an apparent trade-off between stability and functionality could be solved by adding a 
stability design step to the design process, and that structural validation of the thermostabilized 
variant was not required to generate a successful C2-symmetry homodimer.  
Conclusions 
This work represents the first de novo design of a C2-symmetry homodimer via helical interactions. 
The successful design (ENH-c2b) is a monodisperse dimer with a Kd of 130 nM. The solution NMR 
structure is generally consistent with our design model, with the protein-protein interface forming a 
four-helix bundle. The homodimer design was achieved using a two-step computational approach in 
which the wild-type protein (ENH) was first stabilized and subsequently homodimerized. The final 
design (ENH-c2b) is 13°C more stable than ENH, and its sequence identity is 47%. This value is 
notably lower than for other interface designs (80-90%) and can be accounted for by the large 
number of mutations (34) that resulted from stabilization. Our successful homodimer design 
illustrates that the judicious use of computational tools can be employed to generate a stable protein 
with the desired functionality.  
Methods 
Protein Docking and Computational Design. The ENH crystal structure (PDB code: 1ENH) was 
used as the scaffold for homodimerization, with side-chain atoms beyond Cβ deleted and atomic 
radii of the remaining atoms adjusted as follows: N: 1.4 Å, O: 1.3 Å, C!: 1.75 Å, Cα: 2.35 Å, and Cβ: 
2.15 Å. A symmetrical docking program based on a fast Fourier transform (FFT) algorithm was 
applied (32). Arrays used for docking calculations were 64 × 128 × 128 for each of the x, y, and z 
dimensions, with each element corresponding to 1 cubic Å. Each round of searching consisted of 
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extensive translational dockings followed by 1° increments about the y and z axes. Using shape 
complementarity as the criterion, the top 20 conformations for each rotational position were 
identified, combined into a set containing all the top 20s, then ranked. The top 200 of these were 
clustered into 11 groups based on structural similarity (RMSDs), the clusters were visually 
inspected, and one high-scoring model was selected for computational designs. The ORBIT 
computational protein design (CPD) software was used for stability designs for both ENH and 
NC3-NCap. Initial interface designs were also done using ORBIT, and subsequent designs and 
analyses were done using our improved CPD programs, PHOENIX and Triad. Sequence 
optimization was performed using an improved version of FASTER (refs) and a rotamer library 
based on the backbone-dependent library of Dunbrack and Karplus (ref). 
Construct Preparation, Protein Expression and Purification. Oligonucleotides (Integrated DNA 
Technologies) containing ~20 bp overlapping segments were assembled via a modified Stemmer 
polymerase chain reaction (PCR) method (ref) using KOD Hot Start Polymerase (Novagen) to 
generate genes for ENH, ENH-c2a, and ENH-c2b. For SDS-PAGE analysis, a His6 or StrepTag 
II was added to generate His6-ENH, ENH-c2a-Strep, and ENH-c2b-Strep constructs. For all other 
biophysical characterizations, intact ENH-c2b was used. X-ray crystallography was performed on 
an ENH-c2b variant containing 21 additional residues at the N terminus 
(MGSSHHHHHHSSGLVPRGSHM). The construct for solution NMR was ENH-c2b, with an extra 
C-terminal glycine followed by a StrepTag II. All proteins were expressed using BL21 DE3 cells 
transformed by pET plasmids with 1mM isopropyl β-D-1-thiogalactopyanoside (IPTG) in standard 
Luria Broth (LB) at 16°C (His6-ENH and ENH-c2a-Strep) or 37°C (all other proteins). The 13C/15N 
labeled ENH-c2b-Strep for NMR experiments was prepared by growing BL21 DE3 cells in 1 L LB 
until OD600 reached ~0.6 and transferring the cells to 250 mL M9 medium with 13C glucose and 
15N ammonium chloride. Purification of ENH-c2b was accomplished by fusing it to His6-ubiquitin, 
running the construct on a Ni2+-NTA column (Qiagen), then cleaving His6-ubiquitin off using UCH-
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L3 protease (37°C overnight). Strep-Tactin Sepharose (IBA) and Superdex 75 (Amersham 
Pharmacia) columns were used for Strep-tag affinity chromatography and size-exclusion 
chromatography, respectively.  
Circular Dichroism Spectroscopy. CD studies were performed on an Aviv 62A DS 
spectropolarimeter equipped with a thermoelectric temperature controller. Samples were prepared 
in 100 mM sodium chloride and 20 mM sodium phosphate buffer at pH 7.5. Wavelength scans and 
temperature denaturations were carried out in cuvettes with a 0.1 cm pathlength at a protein 
concentration of ~10 µM. Three wavelength scans were performed at 25°C for each sample and 
averaged. The thermal denaturation curve was collected at 222 nm from 0°C to 99°C, sampling 
every 1°C separated by 2 min equilibration times (signal averaging time was 1 sec). The refolding 
curve was collected after the thermal denaturation experiment using the same sample.  
Analytical Ultracentrifugation. ENH-c2b was analyzed on an XL-1 analytical ultracentrifuge 
equipped with an AnTi60 rotor (Beckman Coulter). Two-channel epon-filled centerpieces were 
used for the sedimentation velocity experiment. Cells were torqued to 130 lb-inch and run at 60,000 
rpm. Data were acquired at 230 nm and 20°C in continuous mode. Data were first fit to the c(s) 
model (continuous distribution of sedimentation coefficient) and then converted to the c(M) model. 
(continuous distribution of molecular weight). Time invariant noises and baseline offsets were 
corrected before fitting. A maximum entropy regularization confidence level of 0.95 was used in all 
the size distribution analyses.    
Polarization Fluorescence Assay. Polarization fluorescence was measured at room temperature 
with a Fluorolog-3 spectrofluorometer (HORIBA). ENH-c2b was serially diluted in buffer 
containing 100 mM NaCl and 20 mM TrisHCl at pH 8.0. Fluorescence anisotropy was measured 
for each sample, and the G-factor was determined individually. Data were analyzed according to a 
simple monomer-dimer equilibrium model and fit with KaleidaGraph software. Polarization values 
(mA) for the completely monomeric and dimeric states were fit to be 12 and 251, respectively.  
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X-Ray Crystallography. ENH-c2b crystals were grown at room temperature in 1% w/v tryptone, 
20% w/v polyethylene glycerol 3350, and 0.05 M HEPES sodium at pH 7.0 using hanging-drop 
diffusion. Needle-like crystals appeared within 1 week. The crystals were soaked in glycerol 
cryoprotectant and flash frozen by cold nitrogen stream. Diffraction data were collected at beamline 
BL13C1 at the National Synchrotron Radiation Research Center in Taiwan. The best diffraction 
data had a resolution of ~2.2 Å. However, due to X-ray overexposure, the overall data quality was 
not ideal, so the  data were truncated to 3.5 Å for better refinement. Phases were obtained through 
molecular replacement using ENH (PDB code: 1ENH) as the searching model. Further refinement 
was done with PHENIX. The data statistics are listed in Table 3-3. Final coordinates were deposited 
in the Protein Data Bank with the PDB code 4NDL.  
Solution NMR Experiments. All spectra were acquired at 310 K on a Bruker Avance III 800 
spectrometer equipped with a 5 mm z-gradient TCI (1H, 13C, and 15N) cryoprobe (Bruker, 
Karlsruhe, Germany).  ENH-c2b with an extra C-terminal glycine and Strep•tag II (1.9 mM protein 
in 300 µL) was dissolved in 100 mM NaCl, 5 mM CaCl2, 10 mM DTT, 0.02% NaN3, 5% D2O, and 
20 mM NH4OAc at pH 4.5 in a Shigemi NMR tube (Allison Park, Pa., USA). Assignment of main-
chain and side-chain chemical shifts was based on 1H-15N HSQC, 1H-13C HSQC, CBCA(CO)NH, 
HNCACB, HNCO, HNCACO, HCCH-COSY, HCCH-TOCSY, HBHANH, HNHA(CO)NH, 
(H)CC(CO)NH, H(C)CCONH, HNHA, CACO, CON, and 15N-TOCSY-HSQC experiments. NOE 
distance restraints were obtained from 15N-edited NOESY, 13C-edited NOESY (aliphatic), and 13C-
edited NOESY (aromatic) for intra-chain or inter-chain contacts.  An asymmetrically labeled dimer 
was prepared by mixing 1:1 uniformly 13C/15N labeled and unlabeled ENH-c2b. This sample was 
used for the 12C/14N filtered 13C-edited NOESY experiment (mixing time = 300 ms) in order to 
extract the inter-chain NOE restraints. 1H chemical shifts were referenced to 4,4-dimethyl-4-
silapentane-1-sulfonate (DSS) as the external standard. 15N and 13C chemical shifts were referenced 
using the consensus ratios of the zero-point frequencies at 310 K. Data were processed with 
 
  
58 
Topspin (Bruker) for Fourier transformations and analyzed with CCPN for chemical shift 
assignments.  
Solution Structure Determination. TOLOS+ (ref) was used for φ/ψ restraints predicted by 
backbone chemical shifts. Backbone hydrogen-bond restraints were created between consecutive 
i/i+4 helical residues. φ/ψ restraints, hydrogen-bond restraints, and a set of partially manual NOE 
assignments were used as the initial input for ARIA2.3. Automated NOE cross-peak assignments 
and structure calculations were then applied iteratively by ARIA2.3. For regular NOESY 
experiments, every NOE cross-peak was treated ambiguously as an inter- or intramolecular restraint. 
For the 13C/15N filtered 13C-edited NOESY, the NOE cross-peaks were treated as intermolecular 
restraints only. A C2-symmetry restraint energy term was included. A soft square potential was 
used in the simulated annealing protocol with automated determination of weights for NOE-derived 
restraints. The 7 highest scoring structures out of a total of 32 generated structures were chosen for 
every cycle to obtain assignment statistics. A total of 8 cycles were run and the 10 lowest-energy 
models were refined in explicit water at the end to obtain the final NMR ensemble. The data 
statistics are listed in Table 3-4. 
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Table 3-1. Library design of the homodimer interface 
 9 10 13 14 16 17 18 25 28 32 
Library K AT L A FY FV DFVY AW FY R 
 
Computational library design for homodimerization. Interfacial residues shown above were chosen 
for sequence optimization. The library size was set to 128 members.  
 
 
  
65 
Table 3-2. Sequences of wild-type ENH, ENH-c2a, NC3-Ncap, and ENH-c2b 
   id* 
 
Tm† 
ENH(WT) TAFSSEQLARLKREFNENRYLTERRRQQLSSELGLNEAQIKIWFQNKRAKI  - 49 
ENH-c2a --------KA-DL--YF-------W--Y---R------------------- 82% n/a 
NC3-Ncap -E--E--KR--DE--RRD-R---E--RD--QK-----E--ER--RR-EQQ- 55% 88 
ENH-c2b -E--E--KKA-DLA-YFD-R--PEW-RY--QR-----E--ER--RR-EQQ- 47% 62 
                                                         
The three “coils” at the top show the location of the three helices in the ENH wild-type (WT) fold. 
*id is the sequence identity compared to ENH. 
†Tm is the melting temperature (°C). 
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Table 3-3. Data collection and refinement statistics for the crystal structure ENH-c2b, with an 
extra 21-residue tag at N-terminus (PDB code: 4NDL) 
Statistics Value 
Data collection  
    Space group C2221 
    Cell dimensions  
        a, b, c (Å) 87.6, 167.8, 29.7 
        α, β, γ (°) 90.0, 90.0, 90.0 
    Resolution (Å) 25.9−2.2 
    Rmerge 0.147 
    I/σ 8.0 
    Completeness, % 94.1 
    Multiplicity 5.3 
Refinement  
    Resolution (Å) 24.6-3.5 
    Number of reflections  5697 
    Rwork/Rfree (%) 31/32 
    Number of molecules in asymmetric unit 3 
    Number of atoms 
        Protein 
        Water 
2024 
2023 
               1 
   B factors (Å2) 
       Protein 
       Water 
27.3 
27.4 
17.1 
    R.m.s. deviations 
    Bond lengths (Å) 
    Bond angles (°) 
 
0.009 
1.77 
    Ramachandron map analysis  
        Most favored regions (%) 
        Additional allowed regions (%) 
        Disallowed regions 
 
96.9% 
3.1% 
0.0% 
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Table 3-4. NMR statistics for the structure ENH-c2b-Strep (PDB code: 2MG4) 
NMR structure statistics  
Summary of restraints   
    Total NOE distance restraints 1347 
       Intra-molecular unambiguous 1134 
       Intra-molecular ambiguous 186 
       Inter-molecular unambiguous 26 
       Inter-molecular ambiguous 1 
    Hydrogen bonds 42 
    Dihedral angle restraints (ϕ/ψ) 82/82 
 
r.m.s. deviation from restraints 
 
   NOE restraints (Å) 0.061 ± 0.021 
   H-bond restraints (Å) 0.026 ± 0.010 
   Dihedral restraints (o) 1.16 ± 0.26 
 
r.m.s. deviation from idealized geometry 
 
    Bonds (Å) 0.0051 ± 0.0002 
    Angles (o)  0.72 ± 0.03 
    Improper (o) 1.75 ± 0.17 
 
Coordinate precision r.m.s.d. (Å) 
 
    backbone, secondary structure 0.64 ± 0.23 
    heavy atoms, secondary structure 1.19 ± 0.19 
    backbone, all 1.40 ± 0.40 
    heavy atoms, all 2.20 ± 0.34 
 
Ensemble Ramachandran statistics (%) 
    residues in most-favored region  
 
 
87.9 
    additionally allowed region 
    generally allowed region 
    disallowed region 
7.6 
4.5 
0.0 
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Fig. 3-1.  Steps used to design a C2-symmetrical homodimer. The initial scaffold (ENH) used for 
docking is shown in silver, and the homodimer model used for all interface designs is shown in 
bronze. The number of models created in each step is given in parenthesis.  
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Fig. 3-2.  SDS-PAGE of purified proteins from soluble fractions. The labels are M: marker, 1: ENH, 
2: ENH-c2a, and 3: ENH-c2b. The absence of band in lane 2 indicates that ENH-c2a is not 
expressed in soluble fraction.  
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Fig. 3-3.  Experimental characterizations of the computational library design. (A) Homo-FRET 
assay of the library members. Each dot represents one member in the library. Because of the homo-
FRET effect, members that have lower anisotropic values are likely to have stronger dimer affinities 
or higher oligomeric states. Two representative members, shown in orange (named as ENH_DsD) 
and magenta were chosen for characterizations in B and C. (B) Size-exclusion chromatography 
showed that ENH_DsD (orange curve) is likely a dimer (compared to potein standards) and 
magenta variant formed a higher-order oligomer. (C) Sedimentation velocity experiments showed 
that ENH_DsD is under a fast equilibrium between monomer and dimer states (orange curve); 
magenta variant is a tetramer (magenta curve). The monomer MW is 34.4. kD.  
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Fig. 3-4.  CD spectroscopy shows that ENH-c2b is a fully refoldable helical protein. (A) CD 
spectrum of ENH-c2b at room temperature. Solid line: before thermal denaturation; dashed line: 
after thermal denaturation. (B) Thermal denaturation curve measured at 222 nm. Circles: 
experimental data; line: fitted curve obtained using a two-state transition model. 
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Fig. 3-5.  Characterization of oligomeric state reveals that ENH-c2b is a homodimer with Kd ~130 
nM. (A) Size-exclusion chromatography at 280 nm; experiments were done using loading protein 
concentrations of ~500 µM (black) and 10 µM (gray), indicating dimeric and monomer states, 
respectively. Curves were normalized to 100 to facilitate comparison. (B) Sedimentation velocity 
experiment at 5 µM; curve shows data fit using the c(M) model. The major peak centered at 12429 
Da indicates a dimer (MW of monomer = 6531). (C) Tryptophan homo-FRET assay shows Kd ~130 
nM . Circles: experimental data; dashed line: fitted curve obtained using a monomer-dimer 
equilibrium model. 
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Fig. 3-6. Crystal structure of ENH-c2b with the long N-terminal tag 
“MGSSHHHHHHSSGLVPRGSHM” (PDB code: 4NDL). The two chains in proximity make a 
crystal contact with helix-1 and helix-2. Inspection evaluated by PISA reveals that this contact 
belongs to a crystal packing rather than a biological interface, mainly because of its small area (699 
Å2, the average interface area for a homodimer is 2740 ± 1240 Å2).   
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Fig. 3-7.  Solution NMR structure of ENH-c2b (green) superimposed with design model structure 
(gray), viewed from different orientations. (A-B): superposition of just one chain; (C-D): 
superposition of the entire dimer structure; (E-F): superposition of left chain showing entire dimer 
structure.  
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Fig. 3-8.  NMR spectrum showing intermolecular NOE restraints obtained by 12C/14N filtered 13C-
edited NOESY experiment. Contour plots of [ω1(1H), ω3(1H)]-strips of Ala16Cβ, Ala20Cβ, Leu19δ 
and Leu39Cδ are shown.. Chemical shifts indicated on top and bottom correspond to ω2(13C) and 
ω3(1H) dimensions, respectively. For clarity, only the aliphatic region in the ω1(1H) dimension is 
shown. Unambiguous restraints identified for Ala16, Ala20, Leu19, and Leu39 residues are labeled.  
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Fig. 3-9.  Two-step design strategy for the functional design of homodimers. A single-step design 
for functionality often leads to an unstable protein. Stability design prior to functional design can 
solve this problem. In this work, single-step functional design of ENH led to an unstable protein 
that did not express solubly, referred to as ENH-c2a. However, doing a stability design (NC3-NCap) 
prior to functional design led to a stable homodimer, ENH-c2b. Structures shown are computational 
design models. 
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Computational Design of Self-assembling  
Protein-DNA Nanowires 
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Abstract 
Computation protein design (CPD) has been successfully used to create various kinds of functional 
proteins, including enzymes, protein oligomers, and ligand binders. The ability to rationally design 
molecular self-assembly using biological macromolecules is of particular interest because of its 
versatility for applications in biotechnology and medicine. Sophisticated single-component 
nanostructures composed of nucleic acids or proteins have been demonstrated, but despite these 
successes, the development of hybrid self-assemblies of nucleic acids and proteins via non-covalent 
interactions remains elusive. Here, we used CPD to create a protein-DNA complex that can self-
assemble into nanowires. To achieve this, a homodimerization domain was engineered into the 
transcription factor engrailed homeodomain (ENH) so that it could bind to two DNA molecules on 
the two opposite sides. The homodimerization domain was designed de novo, whereas ENH’s 
native DNA-binding domain was exploited to bind a specific double-stranded DNA (dsDNA) motif. 
When dsDNA fragments containing multiple copies of this motif were combined with the 
engineered ENH homodimer, the two components polymerized via non-covalent interactions to 
form nanoparticles. Particle formation was completely inhibited by adding single binding-site 
dsDNA, confirming that self-assembly occurred via the specified protein-DNA interactions. 
Furthermore, if the dsDNA fragment contains only two binding motifs on the exact opposite sides, 
the protein-DNA self-assembly led to nanowires as visualized by atomic force microscopy. The 
diameter of the nanowire is about 10 nm, which is consistent with the length of the dsDNA 
fragment. The length of the nanowire is up to 300 nm. The protein-DNA co-crystal structure 
confirmed that the nanowire is formed via the designed interactions. To the best of our knowledge, 
this is the first example of DNA-protein nanomaterial that is self-assembled via pure non-covalent 
interactions. 
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Introduction 
Biomolecular self-assembly is an essential process for living organisms as well as a bottom-up 
approach for bio-nanotechnology (1). The ability of scientists to control the self-assembly of 
macromolecules, including nucleic acids and proteins, has progressed significantly in the past 
decade. DNA has been engineered into “origami,” which has led to the creation of seemingly 
arbitrary two- and three-dimensional nanomaterials (2). DNA self-assemblies have been shown to 
have many useful applications ranging from drug delivery (3) to molecular computing (4). The 
design of protein self-assemblies, in contrast, has proved to be more challenging, owing in part to 
our incomplete understanding of protein folding and protein-protein interactions. Nevertheless, a 
single polypeptide chain comprised of a concatenation of coil-coiled motifs was recently designed 
to fold into a defined tetrahedron nanostructure (5). Moreover, highly symmetrical tetrahedral and 
octahedral oligomeric protein cages have been computationally designed with atomic level accuracy 
(6).  
The functionality of these nucleic acid or protein materials, however, has been limited by 
the physical/chemical nature of a single building block. To develop integrated materials with 
multiple cooperative functions, it is advantageous to use two or more kinds of building blocks for 
self-assembly. Hybrid materials in which at least one of the components has a characteristic length 
in the nanometer range often exhibit superior properties over single-component materials. Self-
assemblies of protein and DNA, for example, have been engineered for the highly sensitive 
detection of proteins (7) and for the programmed positioning of multienzyme cascades (8).  To the 
best of our knowledge, all protein-DNA hybrid materials engineered to date use chemical 
conjugations to link the DNA and protein molecules either covalently or through a streptavidin-
biotin interaction. Depending on chemical conjugation for self-assembly, however, complicates 
building-block synthesis considerably and can lead to heterogeneous labeling problems.  
Designing a protein-DNA self-assembly driven by non-covalent interactions holds great 
promise, but is hindered by our limited understanding of protein-protein and protein-DNA 
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interactions. Recent work has demonstrated the engineering of novel protein-protein interfaces (9, 
10) and the alteration of protein-DNA binding specificity (11). The creation of a protein-DNA self-
assembly, however, raises the additional complex problem of successfully arranging these binding 
interfaces to allow complex formation. Any self-assembly with a homogeneous composition 
requires that at least two binding sites or domains exist on every building block. Natural proteins 
frequently use a multi-domain approach for complex tasks. For example, many transcription factors 
use dual DNA-binding and oligomeric activating domains to achieve precise control of gene 
regulation (12).  
Computational protein design (CPD) is a powerful tool that has recently been applied to 
create proteins with new functionality. In the last few years, enzymes have been designed de novo 
to catalyze non-natural enzymatic reactions (13-16), and protein interactions have been designed to 
generate novel heterodimers (10), homodimers (9), and ligand binders (17) with Kd values as low as 
the nanomolar range. Most functional protein designs to date have focused on building a desired 
functionality into a protein, while the protein’s native function is ignored or even lost. In a 
successful recent counter-example, King et al. designed protein nanomaterials with atomic level 
accuracy using native trimers as building blocks, computationally adding a new protein-protein 
interface to a protein that had an existing trimerization interface (6). These two interfaces together 
allow the protein to self-assemble into a highly symmetrical cage, emphasizing the power of having 
two cooperative functions in a single protein.   
Here, we propose an analogous strategy to make self-assembled DNA-protein nano-objects 
via non-covalent interactions. The strategy relies on the judicious design of a dual-function protein 
with two independent binding domains: a homodimerization domain and a DNA-binding domain. 
This designed protein should form a homodimer, with each constituent monomer binding a specific 
fragment of double-stranded DNA (dsDNA). If the dsDNA has multiple specific binding sites for 
the protein, we expect to see spontaneous self-assembly of a protein-DNA complex. We first test 
the homodimerization and DNA-binding functionalities of our designed protein and subsequently 
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show that the designed protein self-assembles with its target dsDNA to form nanoparticles. 
Moreover, if we designed the dsDNA with exact two binding sites located on the opposite sides, the 
protein-DNA self-assembly formed nanowires. Finally, we demonstrate the functionality of the 
protein-DNA nanoparticles and discuss potential applications and further studies.  
Results   
Scaffold Selection. In selecting our scaffold protein, we required that it have two clear binding 
domains, one for DNA binding and one for protein-protein homodimerization. Additionally, the two 
domains had to be adequately removed from each other structurally so as not to conflict with 
binding and to permit large-scale complex assembly. Because the de novo design of DNA-binding 
functionality into a protein has not yet been achieved, we decided to use an existing DNA-binding 
interface in this study. The helix-turn-helix motif is one of the most abundant DNA-binding motifs 
in natural proteins (18). Its principal mechanism of action is the interaction of a positively-charged 
helix with the major groove of dsDNA in a sequence-specific manner. We chose engrailed 
homeodomain (ENH) as our scaffold for the following reasons: (1) a previous study showed that a 
single-helix peptide isolated from ENH can bind a target dsDNA motif (TAATNN) as tightly as the 
full-length protein (Kd in nM range) (19); (2) ENH has been intensely studied using computational 
tools, so highly stable variants as well as full-sequence redesigns have been generated (20, 21); and 
(3) ENH is a three-helix protein, providing a surface for homodimer interface design that is 
structurally separated from the DNA-binding functionality. The surface targeted for 
homodimerization comprises helices 1 and 2, which are anti-parallel to each other and opposite 
DNA-binding helix 3. This large, flat surface shares no residues or secondary structure with the 
DNA-binding domain. In addition, this potential homodimerization domain is on the opposite side 
of the DNA-binding domain. The spatial arrangement of these two binding sites can possibly be 
used to self-assemble a linear structure, like nanowires. Thus, we expected ENH would serve as an 
excellent scaffold for the design of a protein-DNA self-assembling nanostructure.   
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Design Protocol. Figure 4-1 illustrates our protein-DNA nanomaterial design strategy. Using the 
Drosophila melanogaster ENH crystal structure (PDB code: 1ENH) (22) as our docking subunit 
(Fig. 4-1A), we performed fast Fourier transform-based docking to generate C2 symmetrical 
homodimer models (23). The best model exhibited parallel intermolecular helical packing between 
helices 1 and 2 of each of the ENH monomers. CPD was then used to design the interface residues 
of the docked model to minimize the free energy of the intermolecular side-chain interactions (Fig. 
4-1B). Early design variants were characterized and iteratively improved with the use of a molecular 
dynamics screening protocol (24, 25). We named the final designed variant dualENH because it has 
dual functionality: it can both homodimerize and bind dsDNA. A dualENH homodimer serves as 
the protein building block for nanomaterial assembly because it has two binding sites for dsDNA 
(one on each of two opposite faces of the homodimer), as shown in an aligned model (Fig. 4-1C). 
The second designed component of the nanomaterials is a dsDNA building block with protein 
binding sites variously placed along the double helix (Fig. 4-1D and Fig. 4-2A). By tuning the 
positioning of binding sites on the dsDNA and then simply mixing the two designed components 
(DNA and protein) together, we were able to achieve co-assembly of both irregularly shaped 
particles of protein and DNA (Fig. 4-2B) and well-ordered protein-DNA nanowires (Fig. 4-1E). 
Biophysical characterization of dualENH. A synthetic gene encoding the dualENH sequence was 
constructed with a C-terminal (His)6-tag, cloned into an expression plasmid, and transformed into 
Escherichia coli cells. Expression of dualENH at 37 °C produced >10 mg of soluble protein per 
liter of E. coli culture. Far-UV circular dichroism (CD) spectroscopy showed that dualENH is a 
fully refoldable, entirely α-helical protein (Fig. 4-3A). The CD curve for dualENH is very similar to 
that of wild-type ENH, suggesting a high degree of structural similarity. Thermal denaturation 
monitored by CD showed that dualENH has a melting temperature (Tm) of 59 °C (Fig. 4-3B), which 
makes it more stable than wild-type ENH (Tm = 49 °C).  
Size-exclusion chromatography and analytical ultracentrifugation were used to determine 
the oligomeric state of dualENH. Different initial concentrations of dualENH were run over a 
 83 
Superdex 75 size-exclusion column. As the protein concentration was reduced, the peak elution 
volume gradually moved from an earlier position (~14 ml) to a later position (~19 ml) (Fig. 4-4A), 
indicating that dualENH is present in different oligomeric states at different concentrations. To 
determine its oligomeric state explicitly, a sedimentation velocity experiment was run, which 
showed that the principal dualENH species present at 40 mM is a homodimer, with a very small 
amount of higher-order oligomers (Fig. 4-4B).   
We used fluorescence polarization to determine whether dualENH binds dsDNA probes 
strongly and specifically. The polarization will increase if a dsDNA probe is bound by dualENH 
due to a reduction in the tumbling rate of the larger complex. We used a fluorescein-labeled dsDNA 
probe containing the ENH binding motif TAATTA (probe-1) that had previously been used in wild-
type ENH binding studies (26). The polarization of a 25 nM solution of probe-1 increased from its 
intrinsic value of ~140 mP to a plateau of 210 mP as the concentration of dualENH was increased 
from 0 nM to 100 nM (Fig. 4-4D). The same experiment run with wild-type ENH showed a very 
similar trend and polarization values (Fig. 4-5A), indicating that dualENH and wild-type ENH have 
similar binding affinities to probe-1. To test the binding specificity, we designed probe-2, which is 
identical to probe-1 except for a single mutation to its binding motif (TA[C]TTA). Compared to 
probe-1, a weaker response was observed between probe-2 and dualENH: polarization increased to 
only 176 mP at 100 nM dualENH and did not plateau until the concentration of dualENH reached 
10 µM (Fig. 4-4D). An additional probe that had previously been used as a negative control (27) for 
wild-type ENH binding was also tested. As expected, neither dualENH nor wild-type ENH showed 
observable binding to this probe at 100 nM of protein (Fig. 4-5B). Together, these data show that 
dualENH binds strongly and specifically to the wild-type ENH binding motif, TAATTA. 
 We next sought to confirm that each dualENH homodimer could bind two dsDNA fragments as  
illustrated in Fig. 4-1C. Using a Förster resonance energy transfer (FRET)-based experiment, a 15-
nt dsDNA sequence (TAA)5 was labeled with Cy3 or Cy5 dye to serve as a FRET donor or acceptor, 
respectively. We mixed the two labeled (TAA)5 probes with dualENH and observed a strong FRET 
 84 
signal as shown in Fig. 4-4E indicating that the two pieces of dsDNA were brought within Förster 
distance by dualENH. These experiments indicate that the DNA-binding domain and the 
homodimerization domain of dualENH are structurally independent, and that they can function 
cooperatively.    
Co-assembly of Protein-DNA materials. We then devised an experiment to determine whether 
these two functions could act synergistically to self-assemble protein-DNA nano-objects with 
specific dsDNA fragments. We sought to observe the protein-DNA self-assembly using 
fluorescence microscopy. Figure 4-6A shows that nanoparticles were formed immediately after 5 
µM dualENH was mixed with 2 µM (TAA)5. The particles were irregularly shaped with diameters 
of up to several microns. The irregularity of shape was expected because (TAA)5 has four ENH 
binding sites (TAATAA) that each face in a different direction off of the dsDNA helix, which 
causes particle growth to occur in a random branching pattern (Fig. 4-2B). The particles are 
invisible under bright-field microscopy (Fig. 4-7B) because of the transparency of protein and DNA 
to visible light. A control experiment showed that a solution of (TAA)5 by itself did not form any 
particles (Fig. 4-7C). When lower concentrations of dualENH (500 nM) and (TAA)5 (200 nM) were 
used, a smaller and more uniform particle distribution was observed (Fig. 4-7D). Further decreasing 
protein concentration (< 200 nM) significantly reduced the number of particles formed (Data Fig. 4-
7E). This reduction may be due to dissociation of the homodimer at low concentrations. To confirm 
that nanoparticle formation occurs via the proposed mechanism (Fig. 4-2B), we designed a particle 
inhibition experiment using dsDNA with a single binding site as the inhibitor. The single binding 
site on these dsDNA should terminate particle growth. Preincubation of 500 nM dualENH with only 
trace amounts of single-binding-site dsDNA (5 nM) abolished particle formation completely when 
200 nM (TAA)5 was added (Fig. 4-7F). 
To form a linear protein-DNA co-assembly as illustrated in Fig. 4-1E, the dsDNA building 
block must have two protein binding sites about 180º apart on the dsDNA double helix (Fig. 4-1D). 
We designed a 25-nt dsDNA molecule with an 11-nt binding motif (TAATTTAATTT, named 
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motif-11) that contains two ENH binding motifs (TAATTT) facing in opposite directions off of the 
helix. At the same protein and DNA concentrations used in the earlier particle-forming experiment 
(5 µM and 2 µM, respectively) (Fig. 4-6A), dsDNA containing motif-11 and dualENH formed much 
smaller and more uniform particles, with none growing greater in size than the diffraction limit 
(submicron) (Fig. 4-6B). The reduced particle size may be a result of fewer protein binding sites on 
the DNA building block (2 vs. 4). Fewer protein binding sites would decrease the entropy of self-
assembly and increase the chance of binding-site poisoning. We used atomic force microscopy 
(AFM) to study the topology of the protein-DNA co-assembly formed with dualENH and the two-
binding-site dsDNA. Nanowire structures were clearly observed with a width of ~15 nm and a 
length of up to ~300 nm (Fig. 4-8A, B). In accordance with the design model, the observed width of 
the nanowires (~15 nm) is consistent with the length of the dsDNA (~9 nm), considering that AFM 
usually overestimates the length in the x-y plane due to the size of the tip. The height of the 
nanowire is ~1.0 nm (Fig. 4-8C), which is on the order of the diameter of a dsDNA fragment (~2 
nm); the decreased height could be due to compression by the hard AFM tip (k = 3 N/m).  
We solved the co-crystal structure of dualENH and a dsDNA probe containing motif-11 
(Fig. 4-9). The co-crystal structure confirms the dual functionality of dualENH: (1) dualENH uses 
helix-3 to bind dsDNA just as wild-type ENH does, and (2) dualENH uses the surfaces of helix-1 
and helix-2 to form a homodimer (Fig. 4-9A). However, the co-crystal structure reveals two 
homodimer configurations of dualENH that differ slightly from each other, as seen by their 
backbone root mean square deviation (RMSD) of 4.0 Å (Fig. 4-9B). This unexpected result might 
be caused by crystal packing forces, especially as each dsDNA molecule in the crystal forms a 
superhelix (see end-to-end packing of dsDNA fragments in Fig. 4-10A). Given this observation, we 
cannot conclude that either of the observed dualENH dimers in the crystal structure reflects the 
predominant dimer structure in solution. The two dualENH dimer crystal structures have backbone 
RMSDs to the design model of 3.8 Å and 3.9 Å, respectively (see Fig. 4-10B, C). The co-crystal 
structure also confirms that dualENH binds the dsDNA with its designed 11-nt binding motif; 
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however, it also reveals two configurations of protein-DNA binding. One configuration is consistent 
with our design model in which two dualENH molecules bind to the 11-nt motif exactly opposite 
each other on the dsDNA double helix (Fig. 4-9C). The other configuration, however, features one 
of the dualENH bindings in an inverted orientation; i.e., it binds to the reverse complementary 
sequence (AAATTA) of the optimal binding motif (TAATTT) (Fig. 4-9D). This suboptimal 
binding has also been seen in other ENH crystal structures(28), presumably due to the high 
concentrations of protein and DNA used for crystallization. Because of this alternate protein-DNA 
binding configuration, the nanowire in the co-crystal structure is slightly kinked; nevertheless, an 
infinitely repeated protein-DNA nanowire is observed (Fig. 4-9E).  
We used CPD to design a protein-DNA nanomaterial, whose co-assembly is purely driven 
by non-covalent interactions. Unlike assemblies that rely on chemical conjugations, non-covalent 
self-assemblies can be tuned by altering the reaction conditions (e.g., temperature, pH, salt 
concentration). Indeed, our protein-DNA nanostructures will not form in high concentrations of salt 
because the protein-DNA electrostatic interaction is shielded (see Fig. 4-11). Very recently, King et 
al. developed a co-assembling system for protein nanomaterials, in which two different proteins are 
required for assembly (27). Co-assembling systems provide several advantages over single-
component self-assemblies, including better control over the localization and timing of assembly, 
and greater functional and structural versatility of the assembly, as each component can confer 
unique attributes, especially in the case of hybrid materials such as those designed here. The 
protein-DNA nanostructures we designed could be further functionalized with the incorporation of 
engineered DNA structures, such as DNA origami or DNA aptamers. Furthermore, dualENH could 
be fused to peptide tags for antibody recognition or used for the specific attachment of organic and 
inorganic materials(29). We anticipate that protein-DNA co-assembly will open up many new 
possibilities for advanced biomaterial designs.    
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Discussion 
CPD has been used to create a wide variety of functional proteins, from enzymes and homo- and 
hetero-dimers to small molecule binders and protein nanomaterials. Here, we used CPD to design 
the first protein-DNA nanoparticle whose self-assembly is driven by non-covalent interactions. Our 
results demonstrate that self-assembly can be achieved by engineering a dual-function protein that 
can both homodimerize and bind to a specific DNA fragment. We exploited the naturally occurring 
protein-DNA interaction of ENH and created a novel homodimer interaction via CPD. The 
homodimer and DNA-binding interactions occur on two non-overlapping interfaces, which allows 
them to function independently and concurrently. We designed an ENH homodimer that provides 
two binding sites for dsDNA, chose a dsDNA molecule with two opposite protein binding sites, and 
showed that self-assembly of protein-DNA nanowires occurs spontaneously. To the best of our 
knowledge, this is the first example of protein-DNA self-assembling nanomaterial formed via non-
covalent interactions.  
This multiple binding site approach has been used previously to drive the self-assemblies of 
protein-protein (30), protein-DNA (31), and protein-inorganic (32) nano-objects, but many of these 
nanomaterials required engineering of covalent attachments. Frequently, naturally occurring 
interactions have been leveraged to arrive at these self-assemblies, such as the homo-tetramerization 
of streptavidin and the streptavidin-biotin interaction. In these cases, chemical conjugations are 
necessary for the biotinylation of building blocks, which illustrates a disadvantage of this method. 
Protein biotinylation is usually targeted to specific amino acid side-chains, such as lysine or 
cysteine. If a protein has multiple exposed lysines or cysteines, the site-specificity of the labeling 
cannot be controlled. This results in heterogeneous labeling, which allows the haphazard formation 
of multiple types of assemblies created via different streptavidin-biotin interactions. In contrast, our 
self-assembled nanoparticles do not require any chemical conjugations, as they are driven by non-
covalent interactions. More importantly, the binding sites for both protein-protein homodimerizaion 
and protein-DNA binding are specific and well-defined.   
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Materials and Methods 
Protein docking and computational design. The details of protein docking and computational 
design were described elsewhere (25). Briefly, the ENH crystal structure (PDB code: 1ENH)(22) 
was used as the scaffold for homodimerization. A symmetrical docking program based on a fast 
Fourier transform (FFT) algorithm was applied (23), and one high-scoring model was selected for 
computational designs. Homebuilt CPD software was used for symmetry-constrained homodimer 
designs. Sequence optimization was performed using an improved version of FASTER (33) using a 
rotamer library based on the backbone-dependent library of Dunbrack and Karplus (34). The 
sequences of dualENH and wild-type ENH are listed in Table 4-1. 
Construct preparation, protein expression, and purification. Oligonucleotides (Integrated DNA 
Technologies) containing ~20 bp overlapping segments were assembled via a modified Stemmer 
polymerase chain reaction (PCR) method (35) using KOD Hot Start Polymerase (Novagen) to 
generate genes for wild-type ENH and dualENH. A His6 tag and a Gly-Ser linker (GGSGG) were 
added to the C terminus. Proteins were expressed using BL21 DE3 cells transformed by pET 
plasmids with 1 mM isopropyl β-D-1-thiogalactopyanoside (IPTG) in standard Luria Broth (LB) at 
37 °C. Proteins were purified from supernatant of lysed cells using affinity chromatography (Ni2+-
NTA, Qiagen) followed by size-exclusion chromatography (Superdex 75, Amersham Pharmacia). 
Expression of dualENH at 37 °C produced >10 mg of soluble protein per liter of E. coli culture. 
Circular dichroism spectroscopy. CD studies were performed on an Aviv 62A DS 
spectropolarimeter equipped with a thermoelectric temperature controller. Samples were prepared 
in 100 mM sodium chloride and 20 mM sodium phosphate buffer at pH 7.5. Wavelength scans and 
temperature denaturations were carried out in cuvettes with a 0.1 cm pathlength at a protein 
concentration of ~10 µM. Three wavelength scans were performed at 25 °C for each sample and 
averaged. The thermal denaturation curve was collected at 222 nm from 0 °C to 99 °C, sampling 
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every 1 °C separated by 2 min equilibration times (signal averaging time was 1 sec). The refolding 
curve was collected after the thermal denaturation experiment using the same sample.  
Analytical ultracentrifugation. dualENH was analyzed on an XL-1 analytical ultracentrifuge 
equipped with an AnTi60 rotor (Beckman Coulter). Two-channel epon-filled centerpieces were 
used for the sedimentation velocity experiment. Cells were torqued to 130 lb-inch and run at 60,000 
rpm. Data were acquired at 280 nm at 20°C in continuous mode. Data were first fit to the c(s) model 
(continuous distribution of sedimentation coefficient) and then converted to the c(M) model 
(continuous distribution of molecular weight). Time invariant noises and baseline offsets were 
corrected before fitting. A maximum entropy regularization confidence level of 0.95 was used in all 
the size distribution analyses.    
Polarization fluorescence assay. Polarization fluorescence was measured at room temperature 
with a Synergy 2 (BioTek). All DNA oligonucleotides were purchased from Integrated DNA 
Technologies without further purification. The three probes have the following sequences: 
CGCAGTGTAATTACCTCGAC (Probe-1), CGCAGTGTACTTACCTCGAC (Probe-2), and 
CAGGCAGCAGGTGTTGGACT (negative control). The 3! terminus of each probe was labeled 
with fluorescein. The dsDNA samples were prepared by mixing equimolar single-stranded DNA 
with its complementary sequence. The mixture was heated to 95 °C for 10 min and gradually cooled 
down to room temperature. dualENH was serially diluted in buffer containing 20 mM Tris-HCl and 
100 mM NaCl at pH 8.0, except for the NaCl-dependent experiments in Fig. 4-11A. Concentrations 
of all probes were kept at 25 nM. The total volume of each sample was kept at 200 µl. The 
measurements were taken after about a 10-min equilibration. The G factor was calibrated and kept 
at 0.87 for all samples.  
FRET assay. The FRET emission spectrum was measured at room temperature with a Safire2 
(Tecan) plate reader. The (TAA)5 oligonucleotide (oligo) was labeled at its 5! terminus with either 
Cy3 or Cy5. Preparations of dsDNA samples were made as described above. Samples for the FRET 
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experiment were prepared by mixing 400 nM Cy3-(TAA)5 and 600 nM Cy5-(TAA)5 for a reference, 
and then by adding 4 µM dualENH to observe a FRET signal change. The buffer contained 20 mM 
Tris-HCl and 100 mM NaCl at pH 8.0. 
Microscope imaging. All imaging was performed at room temperature on a standard 
epifluorescence microscope (IX71, Olympus) equipped with bright-field and fluorescence 
modalities. The imaging objective was a 40X NA 0.75 objective lens (UPLFLN 40X, Olympus). 
The (TAA)5 oligos were labeled with Cy3 at their 5! terminus. The 11-nt motif oligos 
(CGCAGTGTAATTTAATTTCCTCGAC) were labeled with fluorescein at their 5! terminus. The 
dsDNA samples were prepared as described above. All experiments were done in the following 
buffer: 20 mM Tris-HCl, 100 mM NaCl at pH 8.0, except that the NaCl concentration was 
increased to 150 mM in Fig. 4-11B. 
Atomic force microscopy. Samples were deposited on a mica surface in a buffer containing 100 
mM NaCl, 4 mM MgCl2, and 20 mM TrisHCl at pH 8.0. After a 2-min incubation, the mica surface 
was washed with 3 ml pure water and air-dried. AFM images were taken using repulsive AC mode 
on an Asylum MFP-3D-bio imager, with an AFM tip spring constant of 3 N/m. The scanning rate 
was 1 Hz.  
X-ray crystallography. The dsDNA used for crystallization had forward and backward sequences 
as follow: GTGTAATTTAATTTCC and CGGAAATTAAATTACA. An equimolar mixture of the 
forward and backward oligomers was heated to 95 °C for 10 min and gradually cooled down to 
room temperature. The dualENH (4.9 mM in 1.6 M sodium chloride and 20 mM MES buffer at pH 
5.8) and the dsDNA (5.6 mM in 10 mM TrisHCl at pH 8.0) were mixed in equal volumes. Protein-
DNA co-crystals were grown at room temperature in 0.2 M potassium thiocyanate and 20% w/v 
polyethylene glycerol 3350 at pH 7.0 using hanging-drop diffusion. Diamond-like crystals appeared 
within 1-2 days. The crystals were soaked in 25% ethylene glycol cryoprotectant and flash frozen 
by liquid nitrogen. Diffraction data were collected at beamline 12-2 at Stanford Synchrotron 
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Radiation Lightsource. The best diffraction data had a resolution of ~3.2 Å. Phases were obtained 
through molecular replacement using wild-type ENH-DNA co-crystal structure (PDB code: 3HDD) 
(28) as the searching model. Further refinement was done with PHENIX (36) and Coot (37). The 
data statistics are listed in Table 4-2. 
References 
1. Sarikaya M, Tamerler C, Jen AKY, Schulten K, Baneyx F (2003) Molecular biomimetics: 
nanotechnology through biology. Nat Mater 2(9):577-585. 
2. Rothemund PWK (2006) Folding DNA to create nanoscale shapes and patterns. Nature 
440(7082):297-302. 
3. Jiang Q, et al. (2012) DNA origami as a carrier for circumvention of drug resistance. J Am 
Chem Soc 134(32):13396-13403. 
4. Qian L, Winfree E (2011) Scaling up digital circuit computation with DNA strand 
displacement cascades. Science 332(6034):1196-1201. 
5. Gradisar H, et al. (2013) Design of a single-chain polypeptide tetrahedron assembled from 
coiled-coil segments. Nat Chem Biol 9(6):362-366. 
6. King NP, et al. (2012) Computational design of self-assembling protein nanomaterials with 
atomic level accuracy. Science 336(6085):1171-1174. 
7. Sano T, Smith CL, Cantor CR (1992) Immuno-PCR - very sensitive antigen-detection by 
means of specific antibody-DNA conjugates. Science 258(5079):120-122. 
8. Niemeyer CM, Koehler J, Wuerdemann C (2002) DNA-directed assembly of bienzymic 
complexes from in vivo biotinylated NAD(P)H : FMN oxidoreductase and luciferase. 
Chembiochem 3(2-3):242-245. 
9. Stranges PB, Machius M, Miley MJ, Tripathy A, Kuhlman B (2011) Computational design 
of a symmetric homodimer using β-strand assembly. Proc Natl Acad Sci USA 
108(51):20562-20567. 
 92 
10. Fleishman SJ, et al. (2011) Computational design of proteins targeting the conserved stem 
region of influenza hemagglutinin. Science 332(6031):816-821. 
11. Ashworth J, et al. (2006) Computational redesign of endonuclease DNA binding and 
cleavage specificity. Nature 441(7093):656-659. 
12. Vogel C, Bashton M, Kerrison ND, Chothia C, Teichmann SA (2004) Structure, function 
and evolution of multidomain proteins. Curr Opin Struc Biol 14(2):208-216. 
13. Röthlisberger D, et al. (2008) Kemp elimination catalysts by computational enzyme design. 
Nature 453(7192):190-195. 
14. Privett HK, et al. (2012) Iterative approach to computational enzyme design. Proc Natl 
Acad Sci USA 109(10):3790-3795. 
15. Jiang L, et al. (2008) De novo computational design of retro-aldol enzymes. Science 
319(5868):1387-1391. 
16. Siegel JB, et al. (2010) Computational design of an enzyme catalyst for a stereoselective 
bimolecular Diels-Alder reaction. Science 329(5989):309-313. 
17. Tinberg CE, et al. (2013) Computational design of ligand-binding proteins with high 
affinity and selectivity. Nature 501(7466):212-216. 
18. Brennan RG, Matthews BW (1989) The Helix-Turn-Helix DNA-Binding Motif. J Biol 
Chem 264(4):1903-1906. 
19. Guerrero L, Smart OS, Woolley GA, Allemann RK (2005) Photocontrol of DNA binding 
specificity of a miniature engrailed homeodomain. J Am Chem Soc 127(44):15624-15629. 
20. Marshall SA, Morgan CS, Mayo SL (2002) Electrostatics significantly affect the stability 
of designed homeodomain variants. J Mol Biol 316(1):189-199. 
21. Shah PS, et al. (2007) Full-sequence computational design and solution structure of a 
thermostable protein variant. J Mol Biol 372(1):1-6. 
22. Clarke ND, Kissinger CR, Desjarlais J, Gilliland GL, Pabo CO (1994) Structural studies of 
the engrailed homeodomain. Protein Sci 3(10):1779-1787. 
 93 
23. Huang P-S, Love JJ, Mayo SL (2005) Adaptation of a fast Fourier transform-based docking 
algorithm for protein design. J. Comput. Chem. 26(12):1222-1232. 
24. Mou Y, Mayo SL (Using molecular dynamics simulations to predict domain swapping of 
computationally designed protein variants. submitted to J. Mol. Biol. 
25. Mou Y, Huang P-S, Hsu F-C, Huang S-J, Mayo SL (Computational design and 
experimental verification of a symmetric protein homodimer. submitted to Proc. Natl Acad. 
Sci. USA. 
26. Kalionis B, Ofarrell PH (1993) A Universal Target Sequence Is Bound in-Vitro by Diverse 
Homeodomains. Mech Develop 43(1):57-70. 
27. King NP, et al. (2014) Accurate design of co-assembling multi-component protein 
nanomaterials. Nature 510(7503):103-108. 
28. Fraenkel E, Rould MA, Chambers KA, Pabo CO (1998) Engrailed homeodomain-DNA 
complex at 2.2 angstrom resolution: A detailed view of the interface and comparison with 
other engrailed structures. J Mol Biol 284(2):351-361. 
29. Whaley SR, English DS, Hu EL, Barbara PF, Belcher AM (2000) Selection of peptides 
with semiconductor binding specificity for directed nanocrystal assembly. Nature 
405(6787):665-668. 
30. Ringler P, Schulz GE (2003) Self-assembly of proteins into designed networks. Science 
302(5642):106-109. 
31. Li M, Mann S (2004) DNA-directed assembly of multifunctional nanoparticle networks 
using metallic and bioinorganic building blocks. J Mater Chem 14(14):2260-2263. 
32. Li M, Wong KKW, Mann S (1999) Organization of inorganic nanoparticles using biotin-
streptavidin connectors. Chem Mater 11(1):23-26. 
33. Allen BD, Mayo SL (2006) Dramatic performance enhancements for the FASTER 
optimization algorithm. J. Comput. Chem. 27(10):1071-1075. 
 94 
34. Dunbrack RL, Jr., Karplus M (1993) Backbone-dependent rotamer library for proteins. 
Application to side-chain prediction. J Mol Biol 230(2):543-574. 
35. Stemmer WP, Crameri A, Ha KD, Brennan TM, Heyneker HL (1995) Single-step assembly 
of a gene and entire plasmid from large numbers of oligodeoxyribonucleotides. Gene 
164(1):49-53. 
36. Adams PD, et al. (2010) PHENIX: a comprehensive Python-based system for 
macromolecular structure solution. Acta Crystallogr D 66:213-221. 
37. Emsley P, Cowtan K (2004) Coot: model-building tools for molecular graphics. Acta 
Crystallogr D 60:2126-2132. 
 95 
 Table 4-1.  Sequences of wild-type ENH and dualENH. 
  
       
            o ooo      vv vvv vvv      v  vv  vv    oo oo  oo ooo o  
ENH(WT) EKRPRTAFSSEQLARLKREFNENRYLTERRRQQLSSELGLNEAQIKIWFQNKRAKIKKST 
dualENH   ---------E--KKA-DLA-YFD----PEW-RY--QR----------------------- 
 
The three “coils” at the top show the location of the three helices in the wild-type (WT) fold based 
on PDB structure 1ENH. The DNA-binding domain residues are labeled with “o” and the 
homodimerization domain residues are labeled with “v”. 
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Table 4-2. Data collection and initial refinement statistics for the protein-DNA co-crystal 
structure.  
Statistics Value 
Data collection  
    Space group P4222 
    Cell dimensions  
        a, b, c (Å) 90.1, 90.1, 158.9 
        α, β, γ (°) 90.0, 90.0, 90.0 
    Resolution (Å) 39−3.1 
    Rmerge 0.043 
    I/σ 28.4 
    Completeness, % 99.8 
    Multiplicity 12.7 
Refinement  
    Resolution (Å) 36−3.2 
    Number of reflections  14287 
    Rwork/Rfree (%) 26/32 
    Number of molecules in asymmetric unit 8 
    Number of atoms 
        Macromolecules 
        Water 
        Ligands 
2903 
2903 
0 
0 
   B factors (Å2) 
       Macromolecules 
       Water 
       Ligands 
174.5 
174.5 
n/a 
n/a 
    R.m.s. deviations 
    Bond lengths (Å) 
    Bond angles (°) 
 
0.012 
1.32 
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Fig. 4-1. Protein-DNA nanomaterial design strategy. (A) Helix-1 and helix-2 (green) of ENH were 
engineered into a homodimerization domain, and helix-3 (blue) is the native DNA-binding domain. 
(B) The interface of the docked model was designed for homodimerization. (C) The designed 
homodimer, named dualENH, binds two dsDNA fragments on its outward faces. This model was 
generated by aligning the homodimer model in b with the ENH-DNA co-crystal structure (PDB 
code: 3HDD). (D) Two protein binding sites were engineered onto a dsDNA fragment so that two 
dualENH dimers would bind 180º apart along the double-helix. (E) The dualENH protein in c and 
the dsDNA fragment in (D) co-assemble into a protein-DNA nanowire. Note that this 2D cartoon is 
for purposes of illustration only, and that the 3D design model of the nanowire is spiraled. 
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Fig. 4-2. Design model of irregular bulk protein-DNA nanoparticle. (A) Four consecutive ENH 
binding sites that each face in a different direction are engineered onto a dsDNA fragment. This 
dsDNA building block allows the protein-DNA assembly to occur in all three dimensions. Note that 
in this particular design, two neighboring binding sites may not be simultaneously occupied due to 
steric hindrance. (B) Cartoon illustrating an irregular shaped nanoparticle formed by co-assembly of 
dualENH and the dsDNA shown in (A) The DNA-binding domains of dualENH are shown as blue 
triangles, and the homodimerization domains are shown as green squares. 
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Fig. 4-3. Circular dichroism (CD) spectroscopy of dualENH. (A) CD spectrum of dualENH at room 
temperature. Solid line: before thermal denaturation; dashed line: after thermal denaturation. The 
overlapping of the two curves indicates that dualENH folds reversibly. (B) Thermal denaturation 
curve measured at 222 nm. Circles: experimental data; line: curve fit with two-state transition model. 
The melting temperature of dualENH was determined to be 59 °C. 
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Fig. 4-4. Biophysical characterization of dualENH. (A) Size-exclusion chromatography of dualENH 
with three different loading concentrations: solid line: 650 µM; dashed line: 80 µM; dotted line: 5 
µM. The highest signals were normalized to 100 for all curves. (B) c(S) model fit from a 
sedimentation velocity experiment of 40 µM dualENH. The major peak around S = 1.9 corresponds 
to a MW of 18.3 kD, which is about twice that of monomeric dualENH (8.7 kD). The spike at the 
left (S < 0.5) may be due to impurities or artifacts from model fitting. (C) Raw data and fitting 
residuals for the sedimentation velocity experiment in (B). A total of 378 curves were used for 
fitting, but for visual clarity only 1/5th of the curves are shown. The upper graph shows the raw data 
(dots) and the fitting curves; the lower figure shows the residuals between the experimental data and 
the fit. The square root of variance of the fit is 0.00669. (D) Fluorescence polarization experiment. 
Two dsDNA sequences labeled with fluorescein were used as probes to assay dualENH-DNA 
binding. Probe-1: 20-nt dsDNA with the binding motif TAATTA; probe-2: same sequence as 
probe-1 but with a single-nucleotide mutation to the binding motif (TA[C]TTA). The concentration 
of dualENH was varied, while the concentration of the three probes remained constant (25 nM). 
Data are shown as mean ± s.e.m. for 3 replicates (E) FRET experiment showing that dualENH 
brings two dsDNA fragments within Förster distance. 15-nt dsDNA (TAA)5 were labeled with 
either Cy3 or Cy5 to serve as the FRET donor or acceptor. Gray line: 400 nM Cy3-(TAA)5 + 600 
nM Cy5-(TAA)5; black line: 400 nM Cy3-(TAA)5 + 600 nM Cy5-(TAA)5 + 4 µM dualENH. (F) 
Two control experiments for the FRET experiment in e. Black line: 400 nM Cy3-(TAA)5; Black 
dashed line: 400 nM Cy3-(TAA)5 + 4 µM dualENH; Gray line: 600 nM Cy5-(TAA)5; Gray dashed 
line: 600 nM Cy5-(TAA)5 + 4 µM dualENH. 
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Fig. 4-5. Fluorescence polarization experiments with dualENH and wild-type ENH. (A) 
Fluorescence polarization experiment with probe-1, which contains the binding motif TAATTA of 
ENH. The concentration of dualENH or wild-type ENH was varied, while the concentration of 
probe-1 remained constant (25 nM). Both dualENH and wild-type ENH show saturated binding 
when the protein concentration is at or above 100 nM. Data are shown as mean ± s.e.m. for 3 
replicates. (B) Same experiments as (A), except that a probe without any TAATNN binding motif 
was used. Note that probe-1 used in (A) has a lower fluorescence intensity and polarization than the 
probe used in (B) likely due to partial quenching by a guanine nucleotide on the strand opposite the 
fluorescein label. Data are shown as mean ± s.e.m. for 3 replicates. 
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Fig. 4-6. Fluorescence microscopy of protein-DNA nanoobjects. (A) dsDNA (TAA)5 fragments 
were labeled with the fluorescent dye Cy3. A fluorescent image was taken of particles formed by 
mixing 5 µM dualENH with 2 µM Cy3-(TAA)5 in 20 mM Tris-HCl and 100 mM NaCl at pH 8.0. 
The particles formed irregular shapes up to ~5 µm in diameter. (B) Same experiment as in (A) 
except that 25-nt dsDNA fragments containing motif-11 (TAATTTAATTT) in the middle 
(CGCAGTGTAATTTAATTTCCTCGAC) were used instead of (TAA)5 fragments. All particle 
sizes are under the diffraction limit (submicron). The shapes of the particles are slightly oval instead 
of being symmetrical  (circular) due to moderate geometrical aberrations of the microscopy system. 
 
 
 
 104 
 
Fig. 4-7. Microscope imaging experiments. (A) The size distribution of the irregular protein-DNA 
particles formed by 5 µM dualENH mixed with 2 µM Cy3-(TAA)5. (B) Bright-field microscope 
image of 5 µM dualENH mixed with 2 µM Cy3-(TAA)5. A dust particle (upper-left) is evident, 
indicating the focal plane is correct. (C) Fluorescence microscope image of 2 µM Cy3-(TAA)5 
alone. (D) Fluorescence microscope image of particles formed with 500 nM dualENH mixed with 
200 nM Cy3-(TAA)5. (E) Fluorescence microscope image of particles formed with 200 nM 
dualENH mixed with 100 nM Cy3-(TAA)5. (F) Fluorescence microscope image of particle 
inhibition experiments. A small amount (5 nM) of single-binding-site dsDNA (containing only one 
TAATTA motif) was pre-mixed with 500 nM dualENH, then 200 nM Cy3-(TAA)5 was added. The 
illumination/camera sensitivity was enhanced to confirm that particle formation is nearly 
completely absent under these conditions. 
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Fig. 4-8. Atomic force microscopy of protein-DNA nanowires. (A) Representative AFM image 
obtained after mixing 5 µM dualENH with 2 µM of the two-binding-site dsDNA (25-nt dsDNA 
containing motif-11). Nanowire structures ~15 nm wide and up to 300 nm long are clearly visible. 
(B) Magnified image of a single nanowire ~250 nm in length. (C) 3D topology display of (B) shows 
the height of the nanowire is ~1.0 nm. 
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Fig. 4-9. Co-crystal structure of protein-DNA complex. (A) dualENH forms a symmetric 
homodimer using helix-1 and helix-2 (green) as the protein-protein interface. Helix-3 (blue) binds 
to the dsDNA in the same way that wild-type ENH does. (B) Two forms of dualENH are present in 
the co-crystal structure and occur in a molar ratio of 3:1 (green:cyan). (C), (D) Two forms of 
protein-DNA binding are observed in the co-crystal structure and occur in a molar ratio of 1:1. Both 
have two dualENH homodimers bound on the designed 11-nt motif TAATTTAATTT. In (C), both 
of the dualENH dimers bind in the optimal motif (TAATTT) orientation, whereas in (D), one of the 
dualENH dimers (right) binds in the suboptimal orientation (AAATTA, the reverse complementary 
sequence of the optimal motif). (E), Slightly kinked nanowire structure found in the co-crystal 
structure.  
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Fig. 4-10. Co-crystal structure of the protein-DNA complex. (A) structures in the asymmetric unit 
cell are shown in color, and the end-to-end packing of neighboring DNA molecules and their bound 
proteins are shown in gray. (B), (C) the dualENH homodimer observed in the co-crystal structure 
(green or cyan) is superimposed with the design model (gray). The backbone RMSD to the design 
model is 3.8 Å (green) and 3.9 Å (cyan), respectively. When only one subunit is aligned between 
the more predominant configuration (green) and the design model, the angular displacement 
between the other subunits is ~45˚ with about 3 Å translational displacement. The less predominant 
configuration has a lower angular displacement ~20˚ but a larger translational displacement ~8 Å. 
The calculated energies for the design model and the two crystallographic dimers are -155.2, -140.3 
(green) and -131.2 (cyan) Rosetta energy units, respectively. 
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Fig. 4-11. dualENH-DNA binding and nanostructure formation are inhibited at high salt 
concentrations. (A) Fluorescence polarization experiments of dualENH and probe-1 at various NaCl 
concentraions. Probe-1 and dualENH were mixed in buffers with different NaCl concentrations and 
fluorescence polarization values were recorded. DualENH-DNA binding dropped significantly from 
100 mM to 150 mM NaCl, and was completely absent at 300 mM NaCl. Data are shown as mean ± 
s.e.m. for 3 replicates. (B) Fluorescence image of particle experiment at 150 mM salt concentration. 
The sample was prepared by mixing 500 nM dualENH and 200 nM Cy3-(TAA)5 in 20 mM Tris-
HCl buffer with 150 mM NaCl. The illumination/camera sensitivity was enhanced to confirm that 
particle formation is nearly completely absent under these conditions. 
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Appendix 
Direct Visualization Reveals Dynamics of a Transient 
Intermediate During Protein Assembly 
 
The text of this chapter was adapted from a manuscript coauthored with Xin Zhang, Vinh Q. Lam, 
Tetsunari Kimura, Jaeyoon Chung, Sowmya Chandrasekar, Jay R. Winkler, Stephen L. Mayo, and 
Shu-ou Shan 
Xin Zhang, Vinh Q. Lam*, Yun Mou*, Tetsunari Kimura, Jaeyoon Chung, Sowmya Chandrasekar, 
Jay R. Winkler, Stephen L. Mayo, and Shu-ou Shan (2011) Direct visualization  reveals dynamics 
of a transient intermediate during protein assembly. Proceedings of the National Academy of 
Sciences USA  108, 6450-6455. (*these authors contributed equally) 
Reproduced with permission. 
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Abstract 
Interactions between proteins underlie numerous biological functions. Theoretical work suggests 
that protein interactions initiate with formation of transient intermediates that subsequently relax to 
specific, stable complexes. However, the nature and roles of these transient intermediates has 
remained elusive. Here, we characterized the global structure, dynamics, and stability of a transient, 
on-pathway intermediate during complex assembly between the Signal Recognition Particle (SRP) 
and its receptor (SR). We show that this intermediate has overlapping but distinct interaction 
interfaces from that of the final complex, and is stabilized by long-range electrostatic interactions. A 
wide distribution of conformations is explored by the intermediate; this distribution becomes more 
restricted in the final complex and is further regulated by the cargo of SRP. These results suggest a 
funnel-shaped energy landscape for protein interactions, and provide a framework for understanding 
the role of transient intermediates in protein assembly and biological regulation.  
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Introduction 
Interactions between proteins are central to biology, and underlie numerous molecular recognition, 
regulation, and signaling events (1). A challenge in our understanding of protein interactions is to 
reconcile their fast association kinetics required for biological function (106–108 M-1 s-1) with the 
fact that formation of stable protein assemblies often involves extensive short-range, 
stereospecific interactions that are difficult to accomplish during a single diffusional encounter 
(2-4). This problem becomes more pronounced in protein interactions that require extensive 
conformational changes in the interaction partners. Much theoretical work has suggested that 
assembly of a protein complex initiates with the formation of a transient intermediate held 
together by solvent cage and long-range electrostatic attractions, followed by relative rotatory 
diffusions of the binding partners to search for the optimal interaction interface with shape and 
electrostatic complementarity (4-9). An extreme example of this concept is the “fly-casting 
mechanism”, in which unstructured protein molecules bind targets weakly at a relatively large 
distance, followed by folding at the target site (10-12). In general, formation of transient 
intermediates reduces the dimension of translational and rotational search and could significantly 
accelerate protein association.  
Despite significant progress in theoretical work, direct experimental demonstration of this 
model has been limited, and the structural and dynamic nature of transient intermediates during 
protein interactions has remained elusive. Experimental studies of transient intermediates are still 
at the infant stage, because these intermediates have short lifetimes and are rarely populated at 
equilibrium. Pioneering NMR studies have revealed the structures of rare conformational states in 
equilibrium with the predominant structure in the apo-protein or the final complex, and provided 
direct experimental support for the ability of proteins to explore different conformations (13-17). 
Nevertheless, many of these studies have focused on protein interactions that are inherently weak 
and nonspecific; whether the same principle applies to the assembly of a stable and stereospecific 
protein complex remains to be determined. Further, the transient species probed in this manner do 
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not necessarily represent on-pathway intermediates during complex assembly. To understand the 
protein assembly pathway, it is crucial that on-pathway intermediates during protein assembly 
can be isolated. To this end, we chose the interaction between the Signal Recognition Particle 
(SRP) and the SRP receptor (SR) as a model system. 
Rapid assembly of a stable SRP•SR complex is required to efficiently deliver cargo 
proteins to cellular membranes during co-translational protein targeting, and is essential for 
proper protein localization in all cells (18, 19). Formation of a stable SRP•SR complex is 
mediated by specific interactions between their NG domains (comprised of a GTPase, G-domain, 
and a helical N-domain) (Fig. A-1A). However, free SRP and SR are not in the optimal 
conformation to bind one another, and extensive rearrangements must occur in both proteins to 
attain a stable complex (20). Previous kinetic studies showed that stable SRP-SR complex 
assembly begins with the formation of a transient “early” intermediate (Fig. A-1A, step 1), which 
forms quickly (kon= 5.8 × 106 M-1 s-1) but is unstable (Kd ~ 4–10 µM and koff ~ 62 s-1) (21). This 
intermediate then slowly rearranges (k2~1.5 s-1) to form the final stable complex, which is 
stabilized by a large, continuous interaction surface between the NG-domains of both proteins 
(Fig. A-1A, left panel and step 2) (21). Importantly, complex assembly can be stalled at the early 
intermediate stage by leaving out guanosine 5’-triphosphate (GTP) while maintaining the kinetic 
competence of this intermediate (Fig. A-1A) (21). This allowed us to isolate this intermediate and 
directly characterize its global structure, dynamics, and stability in this work.  The results 
identified distinct interaction interfaces used by the early intermediate, and provided direct 
evidence for extensive conformational search in this intermediate and the importance of long-
range electrostatic interactions in its stability.  Further, the conformational distribution of the 
early intermediate is exquisitely sensitive to the biological cues of the SRP, providing potential 
mechanisms for biological regulation. 
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Results 
Map the binding interface of the early intermediate 
The interaction surface in the stable SRP•SR complex is formed primarily by close contacts 
between their G-domains, with limited contacts between the N-domains near the N-G domain 
interface contributing the remainder of the interface (Fig. A-1A) (20, 22). We first asked whether 
the early intermediate forms the same or distinct interaction interface. To this end, electron 
paramagnetic resonance (EPR) spectroscopy was used to probe the interaction surface (23-25). 
Based on the co-crystal structure of the stable SRP•SR NG-domain complex, we selected residues 
in the vicinity of the interaction surface on SR for replacement by cysteine, which allowed site-
directed spin labeling with the nitroxide probe (1-oxy-2,2,5,5-tetramethyl-3-pyrrolinyl-3-methyl) 
methanethiosulfonate (MTSSL). Only the sites where cysteine replacement and nitroxide labeling 
did not substantially affect the SRP-SR interaction were used for EPR measurements (Fig. A-2A 
and B). The residues on or near the dimer interface are likely to undergo significant changes in 
spin probe mobility upon complex formation. These changes are measured by the linewidth of the 
central resonance (Fig. A-1B and Fig. A-2C and D, DH0) and the overall breadth of the EPR 
spectra, especially the intensity of hyperfine splitting that arises from highly immobile 
populations of spin probes relative to the mobile population (Fig. A-1B, dashed vs. solid arrows) 
(23).  
To validate this approach, we first characterized the interaction surface of the stable 
complex formed with a non-hydrolyzable GTP analogue, 5’-guanylylimido-diphosphate 
(GMPPNP). Twelve residues underwent significant EPR spectral changes upon complex 
formation (Figs. A-1B and A-2C, red vs. black). The majority of spin probes at these positions 
underwent changes in both central linewidth, and the relative population of immobile species (Fig. 
A-1B). For two of these residues, T356 and N426, changes in probe mobility was not obvious 
from the central linewidth but was detectable from changes in EPR spectral shape (Figs. A-1B 
and A-2C). Collectively, these data provided a view of the interaction surface in the stable 
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complex that is consistent with the co-crystal structure (Fig. A-1C, black vs. red outline) (20). 
This validated EPR as a powerful tool to probe the interaction surface of the complex.  
We next used this approach to locate the interface of the early intermediate. Three classes 
of residues were identified that underwent distinct EPR spectral changes upon formation of the 
early or stable complex (Fig. A-1B). Residues in class I, represented by V242 (Figs. A-1B and A-
2C, purple), underwent similar reductions in spin probe mobility upon formation of both the early 
and stable complexes, suggesting that they are involved in the interface of both complexes. 
Residues in class II, represented by S429 (Figs. A-1B and A-2C, brown), underwent substantial 
immobilization of the spin probe in the early intermediate, but these probes became more mobile 
in the stable complex, suggesting that they are engaged in stronger (in the cases of S429 and T451) 
or distinct patterns (in the cases of L433 and E487) of interactions in the early intermediate. 
Residues in class III, represented by I237 (Figs. A-1B and A-2C, green), exhibited substantial 
changes in spin probe mobility only in the stable complex, suggesting that they are specifically 
involved in the formation of the stable complex.  
Collectively, eight residues underwent substantial spectral changes upon formation of the 
early intermediate (Fig. A-1B, classes I and II). Compared to the stable complex, these residues 
reside primarily in or near the N-domain (Fig. A-1C, right panel), suggesting that the early 
intermediate has a detectable interaction surface that partly overlaps with, but is distinct from that 
of the stable complex (Fig. A-1C). In addition, some of the residues that change mobility 
specifically in the stable complex (I237, Q425, N426; Figs. A-1C and A-3, green) were in or 
adjacent to the conserved ‘TAKGG’ and ‘QLLIADV’ motifs, which act as a hinge at the N-G 
domain interface to readjust the relative orientation of the G- and N-domains during stable 
complex formation (20). The absence of significant spectral changes at these positions in the 
early intermediate suggests that this crucial rearrangement has not taken place at the early 
intermediate stage. 
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To independently identify the interaction surface of the early intermediate, we introduced 
24 mutations in SR, all of which map to the heterodimer interface in the stable complex (Fig. A-
4A). These mutations disrupt either the interactions at the dimer interface or the rearrangement at 
the N-G domain interface, and each impairs formation of the stable complex by 5–200 fold (22). 
Several of them were also near the residues engaged in the dimer interface of the early 
intermediate, as identified by EPR (cf. Fig. A-4A vs. Fig. A-1C, right). We tested whether these 
mutations disrupted the stability of the early intermediate using fluorescence resonance energy 
transfer (FRET) between coumarin (DACM) labeled SRP C235 and BODIPY-fluorescein 
(BODIPY-FL) labeled FtsY C487 (21). To our surprise, most of these mutations did not disrupt 
the early intermediate (Fig. A-4B, black bars). Only three mutations caused moderate reductions 
in the stability of the early intermediate (2–4 fold), and a combination of all three mutations 
destabilized the early intermediate by only 8-fold (Fig. A-4B, gray bars and Fig. A-4C).  
The mutational analyses provided independent support for important conclusions from 
the EPR experiments, including the paucity of G-domain interactions and the absence of 
conformational readjustments at the N-G domain interface in the early intermediate.  On the other 
hand, these data raised additional questions, as they showed that the early intermediate was 
insensitive to many mutations near its putative interaction surface identified by EPR. Two models 
to reconcile these results were tested and verified in the experiments below. First, the major 
interactions that stabilize the early intermediate may lie further outside the G-domain and its 
vicinity, where most of the mutations above were located. Second, the early intermediate may not 
have a defined structure but rather contain multiple conformations, each with a distinct interface. 
Mutations that disrupt a specific interface do not affect alternative conformations, and hence do 
not significantly affect the overall stability of the intermediate. In contrast, the stable complex has 
a more defined structure, and hence is more susceptible to mutations that disrupt its interface.  
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Conformational dynamics in the early intermediate 
To test whether the early intermediate samples a broad distribution of conformations, time-
resolved FRET (TR-FRET) was used to measure the distance distribution between donor (DACM) 
and acceptor (BODIPY-FL) dyes labeled at specific sites on SRP and SR in different SRP•SR 
complexes. These measurements provided nanosecond snapshots of fluorescence decay of the 
donor dye (Fig. A-5), from which donor-acceptor distance distributions of the respective complex 
could be derived (26). We analyzed the fluorescence decay curves using both the least-squares 
fitting (Fig. A-6) and maximum entropy (Fig. A-7) methods. These algorithms produce the 
narrowest and broadest distance distributions, respectively, that satisfy the experimental 
measurements, and the distance distributions in the ensemble of SRP-SR complex likely reside in 
between these two extreme representations. Given this, substantial caution was taken in the 
interpretation of the distance distributions, such that the conclusions are largely independent of 
the method used to represent the data. Moreover, we focused on the changes in the distance 
distribution in the different SRP-SR complexes, which are less sensitive to biases introduced by 
different data representation.  
Three pairs of residues were used to measure distance distributions between the G 
domains (Fig. A-7A, G-G), the NG domain interfaces (Fig. A-7B, NG-NG), and the N domains 
(Fig. A-7C, N-N) of both proteins. For all three pairs, the early intermediate exhibited broad 
distance distributions spanning ~25 – 60 Å without a single dominant population (Figs. A-7 and 
A-6, blue). In contrast, the distributions became significantly more restricted in the stable 
complex (Figs. A-7 and A-6, red). For the G-G and NG-NG pairs (Figs. A-7A-B and A-6A-B, red), 
a predominant population was observed in the stable complex with a distance in good agreement 
with the co-crystal structure (33 Å in crystal structure vs. 37 Å for the G-G pair, and 30 Å in 
crystal structure vs. 31 Å for the NG-NG pair) (20). In comparison, the N-N pair displayed a 
broader distribution in the stable complex, with a peak centered around 37 Å (Figs. A-7C and A-
6C, red). This observation can be partially explained by the limited interactions between the N-
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domains in the stable complex, which might allow these domains to have more flexibility (20, 27). 
Taken together, these results provided direct evidence that the early intermediate contained a 
large ensemble of conformations that are similar in stability, whereas the stable complex has a 
more specific structure, particularly at the G-domains and NG-domain interfaces.  
Comparison of these distance distributions also provided clues to the complex assembly 
process. A significant population of molecules with distances as short as ~25 Å was observed for 
the N-N pair in the early intermediate, but this population diminished in the stable complex (Figs. 
A-7C and A-6C). In contrast, a significant population of molecules exhibited long distances (45–
60 Å) for the G-G pair in the early intermediate, which also diminished in the stable complex 
(Figs. A-7A and A-6A). This suggests that SRP-SR complex assembly initiates from close 
contacts between their N-domains in the early intermediate, whereas the G-domains are further 
apart.  
Electrostatic interactions drive formation and stability of the early intermediate 
Consistent with the notion that complex assembly initiates with contacts between the N-domains, 
adaptive Poisson-Boltzmann solver (APBS) calculation (28) revealed clusters of positively and 
negatively charged residues, respectively, on the surface of SRP and SR’s N-domains (Fig. A-8). 
Interactions between these electrostatically complementary surfaces were supported by their 
evolutionary conservation (Fig. A-9A), and by molecular docking simulations using the ClusPro 
2.0 program (29), which generated molecular models for the early intermediate. Two groups, 
each containing an ensemble of ~90 structures, scored significantly higher than all the alternative 
configurations (representatives in each group are shown in Fig. A-8B). In the ‘N’ group, the N-
domains of SRP and SR contact one another via the electrostatically complementary surfaces 
identified in the APBS calculation (Fig. A-8B, left); in the ‘G’ group, the G-domains of the 
proteins contact one another via an interface that is shifted away from the heterodimer interface in 
the stable complex (Fig. A-8B, right vs. inset). The nucleotide-binding cavity of SRP and SR 
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were exposed in both groups (Fig. A-8B, left and right panels), explaining why formation of the 
early intermediate is a nucleotide-independent process.   
Both the ‘N’ and ‘G’ groups represent possible conformations within the ensemble of 
structures of the early intermediate, as all the residues that changed mobility in EPR 
measurements resided on the dimer interfaces of one or the other groups (Fig. A-10A and B), and 
as both groups were needed to reproduce the experimentally observed broad distance distributions 
of FRET probes (cf. Fig. A-10C-E vs. Fig. A-7, blue). Nevertheless, the following strongly 
suggest that the ‘N’ group represents the major conformational ensemble. First, the residues that 
changed spin probe mobility in the early intermediate are primarily in or near the N-domain (Fig. 
A-1C, right panel). Second, most mutations in the G-domain that could affect the ‘G’ group did 
not abolish the stability of the early intermediate, suggesting that the conformers in the ‘G’ group 
are less significantly populated in this intermediate. Third, in Brownian Dynamics calculations 
(30), the association rate constant for the early intermediate estimated for the ‘N’ group agreed 
well with the experimental value, whereas that for the ‘G’ group was 30-fold slower (Fig. A-8C).  
What features in the ‘N’ group make it the major conformation of the early intermediate? 
We reasoned that the complementarily charged surfaces on the N-domains of SRP and SR could 
facilitate the long-range electrostatic interactions that bring the two proteins into proximity (Fig. 
A-8A). To test the contribution of these electrostatic interactions, we generated charge reversal 
mutants in which three basic residues (R35, R49 and K56) on the SRP N-domain were mutated to 
glutamates (RK3E), and the glutamate residues in the EELEE motif on the SR N-domain were 
mutated to arginines (RRLRR). Mutants SRP (RK3E) and SR (RRLRR) severely reduced the 
stability of the early intermediate (Figs. A-8D and A-9C); these mutants also caused 10–28 fold 
reductions in the association rate constant for the stable SRP-SR complex assembly that 
correlated well with their reduced stabilities in the early intermediate (Fig. A-8D, blue, and Fig. 
A-9D).   
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We further asked whether the SRP-SR interaction can be rescued by combining the 
charge reversal mutants of SRP and SR, which partially restores the electrostatic interaction 
between their N-domains (Fig. A-9B). Indeed, the combination of the SRP (RK3E) and SR 
(RRLRR) mutants restored the stability of the early intermediate to within three-fold of that of the 
wildtype protein (Fig. A-8D, black bars and Fig. A-9C). The kinetics of stable complex assembly 
was correspondingly rescued (Fig. A-8D, blue bars and Fig. A-9D). The incomplete rescue could 
be accounted for by the fact that, although the SRP (RK3E) mutation made the SRP N-domain 
highly negatively charged, the SR (RRLRR) mutation rendered the SR N-domain only 
moderately positively charged (Fig. A-9B). Together, these results strongly support the notion 
that electrostatic interactions provide an important driving force to form and stabilize the early 
intermediate, which correspondingly enhances the kinetics of stable complex assembly.  
Cargo restricts conformational dynamics of the early intermediate 
The SRP-SR interaction is profoundly influenced by the cargos of SRP, the ribosome-nascent 
chain complexes (RNCs), which stabilize the early intermediate over 50-fold and accelerate 
stable complex assembly over 100-fold (18, 19). We speculated that the cargo could actively 
regulate the conformational dynamics of the early intermediate. To test this hypothesis, we used 
TR-FRET to measure the conformational distribution of the early intermediate in the presence of 
RNCFtsQ, which contains the first 74 amino acids of a known SRP substrate FtsQ. Notably, the 
cargo substantially altered the distance distribution of all the FRET pairs in the early intermediate, 
changing their broad distance distributions to more bi-modal patterns (Figs. A-7 and A-6, green). 
Thus the cargo restricts the dynamics of the early intermediate to a more limited conformational 
space, in which the successful selection of complementary structures might be enhanced. This 
could partly explain how the cargo enhances the kinetics of SRP-SR complex assembly, and 
therefore effect efficient protein targeting (18, 19). 
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Discussion 
Using the SRP-SR interaction as a model system, we analyzed the global structure, dynamics, and 
stability of an on-pathway intermediate during the assembly of a stable protein complex. The 
techniques used here would not provide atomic resolution information for the assembly 
intermediate; on the other hand, a combination of biochemical, biophysical, and theoretical 
approaches provided a set of complementary and self-consistent information that together 
revealed important global features of this intermediate and shed light on the association process 
of a relatively large and stable protein complex.  
An intriguing finding of this work is that the interaction surface used by the early 
intermediate is quite distinct from that of the stable complex. Electrostatic interactions between 
complementarily charged surfaces on the N-domains of SRP and SR provided the primary 
stabilizing force for the early intermediate. In contrast, more stereospecific interactions between 
the G-domains, which provide most of the driving force for the stable complex, are rather weak at 
this stage of assembly. This explains the previous observations that formation of the early 
intermediate can occur independently of GTP and nucleotides can rapidly exchange in this 
intermediate (21), and is also consistent with a recent cryo-EM analysis of an early cargo-SRP-
SR targeting complex (31). The early intermediate studied herein is considerably more stable (Kd 
~ 4 – 10 µM and koff ~ 62 s-1) than would be expected for encounter complexes, and likely occurs 
at a stage later than simple diffusional encounter. The fact that this intermediate still has a distinct 
interaction surface than the final complex strongly suggests that productive protein-protein 
interactions can initiate at sites that are adjacent to but quite distinct from the final interaction 
surface. 
Besides the electrostatic interaction between the N-domains, a conserved electrostatic 
interaction between Lys399 in the G-domain of SR and the GGAA tetraloop of the SRP RNA 
(the other component of SRP) also provides a crucial contact that stabilizes the early intermediate 
(~12-fold) and accelerates stable complex assembly (32). Despite extensive mutagenesis, these 
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two pairs of electrostatic interactions are the only ones that have been found thus far to contribute 
significantly to the stability of the early intermediate. Together, these results show that formation 
of the SRP-SR early intermediate is driven primarily by long-range electrostatic attractions. 
Consistent with this notion is that the stability of the early intermediate and the rate of stable 
complex assembly have a strong dependence on ionic strength (32).  Critical roles of electrostatic 
interactions in enhancing protein interaction kinetics have been predicted theoretically (33, 34) 
and demonstrated in multiple cases (35-38); our results further emphasize the role of such 
interactions in stabilizing assembly intermediates, which provides an effective way to accelerate 
the overall assembly process.  
Another intriguing finding here is that TR-FRET measurements revealed a broad 
conformational distribution for the early intermediate (Fig. A-11, blue). The broad 
conformational distribution is also supported by the observation that single mutations in the G 
domain do not significantly affect the stability of the early intermediate, whereas a combination 
of these mutations causes a substantial disruption of its stability. This provides direct evidence 
that a wide conformational space is explored by this intermediate, which could aid in the search 
and selection for the optimal structure conductive to forming the stable complex (39). 
Interestingly, the conformational space of the intermediate is actively regulated by the cargo of 
SRP (Fig. 5, green), which restricts the conformation of the early intermediate and produces a 
more bi-modal pattern of distribution. These changes could potentially provide a mechanism to 
exert biological regulation (18, 19). Nevertheless, much more work will be needed to provide a 
molecular understanding of the conformational changes brought upon by the cargo and how these 
changes affect the complex assembly process.  
Formation of the stable complex significantly restricts the distance distributions of both 
the G-G and NG-NG FRET pairs, consistent with the notion that a stable and stereospecific 
complex (Kd ~16 – 30 nM) has a much more defined structure. In comparison, a broader 
distribution of FRET distances was exhibited by the N-N FRET probes, which might arise from a 
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combination of the following factors. First, residual, albeit more restricted, conformational 
sampling still occurs in the stable complex (Fig. A-11, red). Second, interactions in the stable 
complex primarily involve the G-domains and the NG-domain interface, whereas contacts 
between the N-domains are rather limited (Fig. A-1A). Thus the N-domains are likely to have 
more flexibility than the G-domains and can sample different configurations in the stable 
complex.    
The features of the early intermediate during protein assembly bear intriguing analogies 
to molten globules during protein folding, in that both are relatively resistant to many mutations 
and have a broad free energy landscape that allows the protein(s) to sample multiple 
configurations (40). Also analogous to the protein folding process, the energy landscape of 
protein assembly appears to be funnel-shaped, and becomes narrower as the free proteins 
transition through the intermediate and progress towards the steoreospecific complex (Fig. A-11), 
as predicted by theoretical work (7, 10-12, 33, 41). These findings could represent general 
features of transient intermediates during assembly of stable protein complexes, and provide a 
framework to understand their roles in enhancing protein interactions and biological regulation.  
Methods 
Materials. The E. coli SRP and SR GTPases (Ffh and FtsY, respectively) and the 4.5S RNA were 
expressed and purified as previously described (21, 42).  All the experiments in this work use SRP, 
which is the complex of Ffh bound to the 4.5S RNA.  Truncated FtsY (47-497) was used in all the 
fluorescence and EPR measurements, except for the charge reversal mutants FtsY (RRLRR).  The 
abilities of FtsY (47-497) to interact with SRP and respond to the cargo are similar to those of full 
length FtsY (42). Mutant Ffh and FtsY’s were constructed using the QuickChange mutagenesis 
procedure (Stratagene).  All the mutant proteins were expressed and purified using the same 
procedure as that for the wild-type proteins.  Fluorescent dyes N-(7-dimethylamino-4-
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methylcoumarin-3-yl)maleimide (DACM) and BODIPY-FL-N-(2-aminoethyl)-maleimide were 
from Invitrogen.   
RNCFtsQ purification. Homogeneous RNCFtsQ were generated from in vitro translation using 
membrane free cell extract prepared from MRE600 cells, and purified by affinity chromatography 
and sucrose gradient centrifugation as previously described (18, 43).  Purified RNCFtsQ serves as a 
functional cargo in protein targeting, as it can bind SRP, trigger factor, and the secYEG translocon 
complex (43).  In quantitative assays, purified RNCFtsQ exhibited the same affinity for SRP as those 
measured with RNCs that do not contain an affinity tag (44).  
Fluorescence labeling. For FRET measurements, DACM and BODIPY-FL were used to label 
single-cysteine mutants of Ffh and FtsY, respectively, as previously described (21). Labeled protein 
was purified as described (21), and the efficiency of labeling was typically ≥95% with a background 
of <5%. 
Spin labeling.  Single cysteine mutants of FtsY [in 20 mM HEPES (pH 8.0), 150 mM NaCl, and 2 
mM EDTA] were incubated with a 10-fold molar excess of dithiothreitol (DTT) at room 
temperature for 1-2 h to reduce any disulfide bonds.  DTT was removed by gel filtration 
chromatography.  The reduced and degassed proteins (~100 µM) were labeled with a 3–5 fold 
molar excess of MTSSL (Toronto Research Chemicals, Toronto, Canada) at room temperature in 
the dark for 2-3 h.  Excess MTSSL was removed by gel filtration chromatography.  The labeling 
efficiency was determined by EPR using the TEMPO calibration curve (Bruker user manual), and 
was typically > 80% with < 5% background as assessed from the cysteine-less wild-type protein 
using the same procedure.  All the spin-labeled proteins were tested for interaction with SRP using 
the GTPase assay; only the spin-labeled FtsY mutants that did not substantially disrupt activity were 
used for EPR measurements.   
TR-FRET measurements. Time-resolved fluorescence decay measurements were carried out in 
SRP buffer with a picosecond streak camera (C5680; Hamamatsu Photonics) in the photon-
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counting mode (45), using an excitation wavelength of 355 nm generated from a third harmonic of a 
regeneratively amplified mode-locked Nd-YAG laser (pulsewidth is ~ 15 ps) (Vangurd, Spectra-
Physics). A band-pass filter of 450±5 nm was used as the emission filter. There was no observable 
fluorescence from buffer or unlabeled protein.  DACM fluorescence decay kinetics was measured 
in both short (5 ns) and long (20 ns) time scale, with time resolutions of ~10 and ~40 ps, 
respectively. 
TR-FRET conditions. Donor-only measurements were carried out in SRP buffer in the presence of 
5 or 1 µM DACM-labeled SRP for the early and stable complexes, respectively. For the early 
intermediate, 5 µM DACM-labeled SRP and 50 µM BODIPY-FL-labeled SR were mixed together 
in the presence of GDP.  For the stable complex, 1 µM DACM-labeled SRP and 8 µM BODIPY-
FL-labeled SR were mixed in the presence of GMPPNP.  Under these conditions, formation of both 
complexes was complete after a 20-minute incubation at room temperature in dark.   
Numerical analysis for TR-FRET measurements.  The measured short and long time-scale data 
were spliced together, and the combined traces were compressed logarithmically before the fitting 
process (70 points per decade).  The splicing and compression did not introduce artifacts to the 
interpretation of data (26).  Analyses of the TR-FRET data can be described as a numerical 
inversion of a Laplace transform [I(t) = P(k)exp−kt
k∑ ] , in which I(t) is fluorescence intensity, 
k  is the fluorescence decay rate constant, and P(k)  is the probability of a specific k (46, 47).  In 
this work, two algorithms were used to invert the kinetics data with regularization methods that also 
impose a non-negativity constraint, P(k) ≥ 0  ∀k( ) .  The first method, based on the Least-Squares 
(LSQ) fitting, used a MATLAB algorithm (LSQNONNEG) (Mathworks, Natck, MA) that 
minimizes the sum of the squared deviations ( χ 2 ) between observed and calculated values of I t( )
, subject to the non-negativity constraint. This algorithm produces the narrowest P k( )  distributions 
and smallest values of χ 2  with relatively few nonzero components.  The second method is based 
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on the Maximum Entropy (ME) theory.  The information theory proposes that the least biased 
solution to the inversion problem is to minimize χ 2  and maximize the breadth of P k( )  (48). This 
regularization condition can be met by maximizing the Shannon-Jaynes entropy of the rate-constant 
distribution S = − P(k)ln P(k)[ ]k∑{ }  while satisfying the non-negativity constraint. ME fitting 
generated stable and reproducible numerical inversions of the kinetics data. The balance between 
 minimization and entropy maximization is evaluated by the L-curve analysis, which yielded 
upper limits for the widths of P k( )  consistent with experimental data. The P k( )  distributions 
from ME fitting were broader than those obtained with LSQ fitting, but exhibited maxima at similar 
locations.  
Both methods were used to generate the decay rate distribution P k( ) . A coordinate 
transformation using the Förster relation (Eq. 1) was then used to convert the probability 
distribution of the decay rates k  to the donor-acceptor distances , thus generating the donor-
acceptor distance distribution P r( ) .  
r = R0
k
k0
−1"
#
$
%
&
'
1 6
  (1) 
The Förster radius, , for the DACM/BODIPY-FL pair is ~47 Å. The value of k0  was obtained 
from donor-only measurements, which gave a nearly single-exponential (>90%) fluorescence decay 
kinetics for all three positions in this study.  At distances larger than 1.5 R0 , energy transfer does 
not take place efficiently, whereas at distances < ~13 Å, the Förster model does not reliably 
describe FRET kinetics.  Therefore, our TR-FRET measurements can provide information about 
donor-acceptor distances only in the range of 13 – 70 Å.   
Fluorescence anisotropy measurements. Anisotropy measurements used excitation and emission 
wavelengths of 380 nm and 470 nm for DACM and 450 nm and 518 nm for BODIPY, respectively. 
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Fluorescence anisotropy was calculated according to Eq. 2:  
R = IVV −G× IVH( )IVV + 2G× IVH( ) ,
                                                   (2)  
in which IVV and IVH are the vertically and horizontally polarized emission intensities when the 
sample is vertically excited; G is the grating factor that corrects for the wavelength response to 
polarization of the emission optics and detectors, defined as G = IHV/IHH, where IHV and IHH are 
the vertically and horizontally polarized emission intensities when the sample is horizontally 
excited.  
Contribution of dipole orientation and fluorophore linkers to distance distribution. 
Fluorescence anisotropy measurements showed that both the donor and acceptor fluorophores 
exhibited low anisotropy values comparable to the free dye when they were incorporated into the 
proteins. This strongly suggests that the labeled fluorophores are relatively free rotamers with 
randomized orientations. Hence, the orientation factor, κ2, can be approximated by <κ>2 = 2/3. In 
addition, the distance distribution can be widened and/or shifted by the fluorophore linkers. For 
DACM, the linker length is short and very rigid, and thus the primary contribution of the linker is to 
shift the measured distances by ~5 Å.  On the other hand, BODIPY-FL has a long (6 carbon bonds) 
and flexible linker that will widen the distance distribution.  This effect was estimated as one 
effective Gaussian chain with the parameter, rlinker = L× lp , in which L and lP are the contour 
and persistence lengths of the fluorescence linker, respectively (49).  This yielded an estimated rlinker 
value of ~7 Å for BODIPY-FL. 
GTPase assay.  The assay to measure the stimulated GTP hydrolysis reaction between SRP and SR 
was performed and analyzed as described (42).  Briefly, reactions were carried out in SRP buffer in 
the presence of a small, fixed amount of SRP (100–200 nM), varying amounts of SR, and saturating 
GTP (100 – 200 µM).  The observed rate constants (kobsd) were plotted against SR concentration and 
fit to Eq. 3, 
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kobsd = kcat ×
[SR]
Km +[SR]
 , (3) 
in which kcat is the maximal rate constant at saturating SR concentrations, and Km is the 
concentration required to reach half saturation.  Because kcat is at least 100-fold faster than the rate 
of SRP•SR complex disassembly, the rate constant kcat/Km in this assay is rate-limited by and 
therefore equal to the rate of stable SRP-SR complex formation (42).  No DTT was present in the 
reactions involving spin-labeled proteins.  
Docking.  The ClusPro 2.0 docking server was used to generate docking models for the early 
intermediate (50). This program was chosen because it emphasizes the number of energy-preferred 
structures in the docking cluster, and is therefore particularly suitable to generate an ensemble of 
conformations for the early intermediate. During the docking, E. coli Ffh was set as a static 
receptor, while E. coli FtsY was set as a ligand that searched for the best docking position with the 
receptor.  The initial docking positions were generated by the Fast Fourier Transform method 
without using the FRET distances as constraints; and the resulting docking positions were clustered 
according to their root mean squares deviations. The best energy conformations were sorted as 
clusters via a filter that was set to an energy function that favors electrostatic interactions. The 
ranking of the clusters was determined by the number of structures that each cluster contained. The 
top five clusters had 89, 88, 65, 59, and 46 structures, respectively. The top two clusters, named ‘G’ 
and ‘N’, were chosen for further analyses.  
Brownian dynamics. BrownDye was used for Brownian Dynamics calculations (30). APBS was 
used to calculate the electrostatic potentials (28). Partial atomic charges and atomic radii were 
assigned from the PARSE parameter set. The dielectric constants were assigned to be 4 in the 
protein interior and 78 in the exterior. Grids were assigned with dimensions of 193 × 193 × 193 
points. Temperature was set to 298 K and ionic strength was set to 100 mM. Brownian dynamics 
trajectories were started at a minimum intermolecular separation that still gave spherically 
symmetric forces. The number of trajectories to estimate the association rate constants varied from 
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40,000 to 100,000 depending on how fast the rates were. The reaction criterion was specified by the 
atom-contact pairs defined by the structure of the complex. All the intermolecular nitrogen-oxygen 
pairs within 0.55 nm were considered as within the reaction criterion. A series of simulations with 
different levels of reaction criteria was generated by systematically tuning the required atom-contact 
number from 3 to 7. Three structures were used for this analysis to obtain the association rate 
constants: the central structure of the ‘G’ cluster, the central structure of the ‘N’ cluster, and the 
crystal structure of the stable complex.  
EPR. EPR spectra were acquired with a 9.4 GHz (X-band) Bruker EMX EPR spectrometer with an 
ER 4119HS cavity at 20-23 ºC. 40% glycerol was present in all samples to eliminate the global 
tumbling motion of proteins. All scans were carried out using a microwave power of 5 mW, a 
modulation amplitude of 2 gauss and a magnetic field sweep width of 100 gauss. The central 
linewidth of EPR spectra was the same at microwave powers of 0.2 – 5 mW. Averaged spectra were 
obtained from 32 – 64 scans and background signals were subtracted.  
EPR conditions.  EPR measurements were carried out in SRP buffer [50 mM KHEPES, pH 7.5, 
150 mM KOAc, 2 mM Mg(OAc)2, 2 mM DTT, 0.01% Nikkol] to determine the local mobility of 
twenty three spin-labeled FtsY mutants in apo-FtsY, in the early intermediate, and in the stable 
complex.  For apo-FtsY, 75-100 µM spin-labeled protein was used to obtain the EPR spectra.  The 
early intermediate was formed by mixing 30 µM spin-labeled FtsY with 90 µM SRP in the presence 
of GDP.  Based on the affinity of the early intermediate (Kd ~ 4-10 µM) (21), >90% of labeled FtsY 
formed the early complex with SRP under these conditions.  The stable complex was formed by 
mixing 30 µM spin-labeled-FtsY with 60 µM SRP in the presence of GMPPNP.  Over 99% of 
labeled FtsY formed a stable complex with SRP under these conditions, according to the Kd values 
of the stable complex of ~16–30 nM (21).  
Steady-state fluorescence. All measurements were carried out at 25 °C in SRP buffer [50 mM 
KHEPES, pH 7.5, 150 mM KOAc, 2 mM Mg(OAc)2, 2 mM DTT, 0.01% Nikkol] on a Fluorolog-
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3-22 spectrofluorometer (Jobin Yvon, Edison, NJ), using an excitation wavelength of 380 nm and 
an emission wavelength of 470 nm. FRET efficiency was calculated as described (21). To compare 
the relative equilibrium stabilities of the early intermediates formed by different SR mutants, 4 µM 
BODIPY-FL labeled SR was incubated with 1 µM DACM-labeled SRP in the absence of GTP. As 
formation of the early intermediate is rapid but has a high Kd (4 – 10 µM), the FRET value at the 
sub-saturating SR concentration provided a sensitive measure of the changes in its stability.  For 
representative mutants, equilibrium titrations were carried out. The data were fit to Eq. 4
€ 
E = E1×
[SR]
Kd +[SR]
, (4) 
in which E1 is the FRET end point with saturating SR, and Kd is the equilibrium dissociation 
constant of the early intermediate.  
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Fig. A-1 Mapping the interaction interface of the SRP•SR complexes using EPR spectroscopy. (A) 
Left: crystal structure of the SRP•SR NG-domain complex (1JR9). Right: a multi-step mechanism 
for SRP-SR complex assembly involving formation of an early intermediate (step 1), and 
rearrangement to form the stable complex (step 2). Removal of GTP stalls the complex at the 
early intermediate stage. T denotes GTP. (B) Nitroxide spin probes labeled at specific SR residues 
change mobility upon formation of the early intermediate (blue), the stable complex (red), or both. 
The different classes of spin probe mobility changes are defined in the text. Black denotes the 
apo-formed SR. (C) Interaction surface of the stable complex (left) and early intermediate (right) 
mapped by EPR. ‘N’ and ‘G’ denote the N- and G-domains of SRP and SR, respectively. The red 
line outlines the interaction surface in the co-crystal structure (20) of the stable complex.  
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Fig. A-2 The mobility of spin labels on SR changed upon formation of the early intermediate, stable 
complex, or both.  (A and B) Spin-labeled SR were screened using the GTPase assay. The activities 
of spin-labeled (SL) SR’s in interaction with SRP were analyzed using the GTPase assay (see 
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Supplementary Methods).  Two kinetic parameters were assessed: the GTPase rate constants of the 
SRP-SR complex (kcat in A) and the association rate constants for stable SRP-SR complex assembly 
(as determined by kcat/Km in B; see Supplementary Methods). Spin-labeled SR’s that were defective 
in either property by a factor of 5 or more were not used for EPR studies (open bars). Spin-labeled 
SR’s that were functional in interacting with SRP (grey bars) were used for EPR measurements for 
either the early intermediate or the stable complex. (C) Spectra of additional spin probes in SR 
changed mobility upon formation of either the early intermediate or the stable complex. Three 
different classes were defined in the text based on probe mobility changes. The mobility of spin 
label was analyzed from the central line width (ΔH0) and the breadth of the spectra, and summarized 
in Figure 1B. Black, blue, and red denote the free protein, the early intermediate, and the stable 
complex, respectively. (D) EPR spectra of spin probes in SR that exhibited no significant changes 
in mobility upon formation of either complex. Color-coding is the same as in A.  
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Fig. A-3 Residues I237, Q425, and N426 (green), which changed EPR spectra specifically in the 
stable complex, are at the conserved motifs (yellow) that mediate N-G domain rearrangement.  
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Fig. A-4 Mutations that disrupt the stable complex did not significantly affect the early 
intermediate. (A) Positions of SR mutations (cyan and blue) studied herein are shown in the 
surface representation of the SR. The three moderately defective mutants are highlighted in blue. 
(B) The stability of the early intermediate is insensitive to many mutations that disrupt the stable 
complex. (C) The stabilities of the early intermediates formed by mutant SRs were determined by 
equilibrium titrations.  Nonlinear fits gave Kd values of 4.1 µM for wild-type SR, 13.2 µM for SR 
(K306A), 17.3 µM for SR (L393W), and 31.3 µM for SR (K306A:L393W:A421W). 
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Fig. A-5 Fluorescence decay of donor (DACM)-labeled at SRP (C76) under different experimental 
conditions. The black, blue, and red curves represent the decay curves for donor-only, the early 
intermediate, and the stable complex, respectively. The linear decay of the donor-only sample could 
be described by a single decay rate constant.  In contrast, the decay curves in both the early 
intermediate and stable complex deviated from linearity and were described by multiple decay rate 
constants. 
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Fig. A-6 Distance distributions derived from least-squares analyses of the TR-FRET data for each 
FRET pair in the early intermediate (blue), stable complex (red), and early intermediate bound with 
cargo (green). 
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Fig. A-7 Conformational distribution of the early intermediate is broad, and is restricted by 
formation of the stable complex or the cargo. Left, positions of the G-G (A), NG-NG (B), and N-
N (C) FRET pairs in the stable SRP•SR NG-domain complex. Right, FRET distance distributions, 
P(r), for each FRET pair in the early intermediate (blue), stable complex (red), and the early 
intermediate bound to cargo (green), as derived from maximal entropy analyses of the TR-FRET 
data. 
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Fig. A-8 Electrostatic interactions between the N-domains of SRP and SR stabilize the early 
intermediate and accelerate stable complex assembly. (A) The SRP and SR N-domains contain 
complementarily charged surfaces. (B) Molecular docking simulation generated two groups of 
conformations (‘N’ and ‘G’) for the early intermediate. For comparison, the inset in the middle 
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shows the structure of the stable complex with the SRP NG-domain aligned in the same 
orientation. The nucleotide bound to SRP is shown in CPK coloring. (C) The association rate 
constants predicted from Brownian Dynamics calculations for formation of the early intermediate 
in the ‘N’ or ‘G’ group, and for the stable complex. The experimentally measured rate constants 
are in parentheses. (D) Charge complementarity between the N-domains is critical to the stability 
of the early intermediate (black bars) and the kinetics of stable complex assembly (blue bars), 
determined using the FRET and GTPase assays, respectively, for the wildtype proteins (WT:WT), 
wildtype SRP and mutant SR (WT:RRLRR), mutant SRP and wildtype SR (RK3E:WT), and the 
charge reversal SRP and SR mutant pair (RK3E:RRLRR). The kinetic constants were derived 
from the data in Figure S5D.  FRET efficiency in the early intermediate was recorded at 5 µM 
FtsY, at which concentration the FRET value is most sensitive to changes in the stability of the 
early intermediate. 
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Fig. A-9 Charge complementarity between SRP and SR’s N-domains is essential for the stability 
of the early intermediate and the kinetics of stable complex assembly.  (A) Sequence alignment of 
SRP and SR homologues. The residue numbering is for the E. coli SRP and SR proteins. 
Conserved positive and negative residues are denoted in blue and red colors, respectively. (B) The 
R36E:R49E:K56E (R2E) mutation in SRP generated a negative electrostatic potential in the SRP 
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N-domain (left), and the RRLRR mutation in SR generated a moderately positive electrostatic 
potential in the SR N-domain (right). (C) The stabilities of the early intermediates formed by 
mutant SRP and SR’s were determined by equilibrium titrations. Nonlinear fits of data to eq. 1 
(main text) gave Kd values of 4.0 µM for WT:WT (wild-type SRP and SR), 50.1 µM for R2E:WT 
[mutant SRP (R2E) and wild-type SR], and 20.1 µM for R2E:RRLRR [mutants SRP (R2E) and 
SR (RRLRR)]. (D) The kinetics of stable complex assembly. Nonlinear fits of the data gave 
kcat/Km values of 0.72 × 106, 0.056 × 106, 0.080 × 106, and 0.31 × 106 M-1 s-1, respectively, for the 
interaction between the wildtype proteins (WT:WT), wildtype SRP and mutant SR (WT:RRLRR), 
mutant SRP and wildtype SR (RK3E:WT), and the charge reversal SRP and SR mutants 
(RK3E:RRLRR). 
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Fig. A-10 The ‘N’ and ‘G’ groups represent possible conformations within the ensemble of the 
early intermediate (A-B) Spin probes that changed mobility upon formation of the early 
intermediate are close to the interaction surface of either the ‘N’ (magenta residues) or the ‘G’ (red 
residues) group. The SRP NG-domain is in gold, and the SR NG-domain is in green. (C-E) Distance 
distributions of the three pairs of FRET probes predicted by a combination of the docking structures 
in the ‘N’ and ‘G’ groups.  
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Fig. A-11 Model of free energy landscapes for the protein assembly process.  The conformational 
space is broad for the free proteins (grey) and the early intermediate (blue), but becomes more 
restricted in the steoreospecific stable complex (red) or when SRP is bound to the cargo (green). 
 
 
 
 
 
